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Complex Regulation of Protein Trafficking and Photoreceptor Cell Development by Small 
GTPases. 
Zachary C. Wright 
Photoreceptor cells are specialized neurons optimized for the capture of light and the signal 
transduction to downstream cells that provides vision. Proper photoreceptor cell function 
depends heavily on efficient regulation of protein-protein interactions both during development 
and in the adult retina. Despite years of research on photoreceptor development and protein 
trafficking, the components vital to these processes are poorly understood. Interestingly, there 
are a number of small GTPases, which act as molecular switches, that are believed to play a role 
in regulating such interactions throughout the process of ciliogenesis, OS formation and protein 
trafficking. However, research into the role of these proteins in photoreceptor cells is in its 
infancy. Moreover, there are a growing number of discoveries linking small GTPases with 
photoreceptor mediated disease, such as ARL6, ARL2, ARL3, and RAB28. In this work I 
characterize the role of the small GTPases, ARL2 and ARL3, in the regulation of photoreceptor 
cell protein trafficking and OS development. In order to study these proteins in vivo, we utilized 
site-direct mutagenesis and transgenesis to create multiple animal models. Through these 
models, we have discovered that ARL2 and ARL3 serve different primary functions in vivo 
despite their high sequence similarity and sharing a number of binding partners. In Chapter 1 of 
this dissertation, we discuss the potential mechanisms and key players of photoreceptor cell 
ciliary development and protein trafficking. In Chapter 2, data is presented from the first animal 
model we generated expressing dominant active ARL3-Q71L. We further propose a mechanistic 
model for the role of ARL3 in prenylated protein trafficking in photoreceptor cells in which it 
acts to displace lipid modified cargo at the cilium. Chapter 3 focuses on data obtained from our 
dominant active ARL2-Q70L transgenic animal model. Here we discuss the potential role for 
ARL2 in ciliogenesis and OS formation in photoreceptor cells highlighting the novel observation 
that proper ARL2 function is necessary for cilia localization and axonemal extension. Finally, in 
Chapter 4 we discuss the data obtained during my dissertation and strategies to fill the gaps in 
knowledge that remain concerning the role of these small GTPases in photoreceptor cells. This 
work provides a strong foundation for the mechanisms of ARL2 and ARL3 action in 
photoreceptor cells. Complete elucidation of the components involved in photoreceptor protein 
trafficking and OS formation will provide the data necessary to generate novel therapeutics 
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The photoreceptor cell sensory cilium is a complex organelle optimized for capturing light signal 
and transduction of that signal to downstream neurons. This specialized cilium requires a 
regulated series of interactions to produce the final functional outer segment with organized 
membrane discs loaded with phototransduction proteins. There is growing evidence that small 
GTPases play a major role in photoreceptor cell biology, specifically in the development and 
maintenance of the sensory cilium. Small GTPases are molecular switches that orchestrate 
molecular interactions by modifications of the guanine nucleotide binding status and these 
proteins are crucial to a wide range of cellular processes. Here we review the recent advances in 
our understanding of a subset of small GTPases underlying the processes of photoreceptor 
sensory cilium formation and protein targeting to the outer segment. A number of these small 
GTPases have been implicated in retinal degenerative diseases and syndromic ciliopathies. 
Understanding the basic mechanisms through which small GTPases act will provide insight into 
pathological states that will guide therapeutic intervention.  




Photoreceptor cells are highly specialized neurons that utilize a complex modified cilium, the 
photoreceptor outer segment (OS), to efficiently capture light (Pearring et al. 2013). This 
organelle poses major demands in regulation of developmental processes such as OS formation 
as well as maintenance of function by selective trafficking of OS proteins to their site of action. 
Cilia formation, i.e. ciliogenesis, in photoreceptor cells must be efficiently regulated so as to 
allow for creation of a functional, organized outer segment (OS) with stacked membrane discs 
that are packed with phototransduction and structural proteins necessary for sight. A number of 
diseases are the result of malformation of the OS and these diseases often occur because of an 
inherited defect in the genes involved in ciliary formation. These defects result in blinding 
disease as well as syndromic disorders known as ciliopathies, which result from a generalized 
defect in cilia of multiple organs. On the other hand, the demand for efficient protein trafficking 
in the mature OS is a result of the anatomy of the photoreceptor cell which has distinct 
compartments, i.e. the inner segment (IS) where OS proteins are synthesized and the OS where 
those proteins must function to capture light (Nachury, Seeley, and Jin 2010). Correspondingly, 
human disease may result from inefficiency in the process of protein trafficking in photoreceptor 
cells. Notably, mutations that disrupt the transport of phosphodiesterase 6 (PDE6), rhodopsin, or 
other phototransduction proteins are a major cause of the blinding disease, retinitis pigmentosa 
(RP) (Iannaccone et al. 2006; D. Y. Wang et al. 2005). Retinitis pigmentosa (RP) alone is 
responsible for vision loss in 1 in 4,000 people worldwide (Sung and Chuang, 2010). It is critical 
to realize that treatment for this disease is limited and clinical trials have produced very few 
promising results. Gene therapy approaches have been tested with some success, but have not yet 
produced overwhelming effectiveness (Petrs-Silva and Linden 2013; Rossmiller, Mao, and 
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Lewin 2012). Despite the importance of OS development and efficient trafficking of proteins in 
photoreceptor cells, the mechanisms behind the regulation of these processes are poorly 
understood.  
Cilia development and targeted protein trafficking require methods for regulating 
protein:protein and protein:lipid interactions a specific locations and timepoints. Small GTPases 
are a major family of proteins that are specialized to function based on the immediate subcellular 
environment making them optimized for this function. Small GTPases are known regulators of 
protein and vesicular trafficking as well as developmental processes in other cell types, however, 
they are understudied in the realm of photoreceptor cell biology. The aim of this review is to 
discuss the emerging role of small GTPases in the major processes of photoreceptor cell biology 
including OS/ciliary development and polarized trafficking of phototransduction machinery.  
SMALL GTPases 
Small GTPases are molecular switches that have a wide range of functions acting as key 
regulators in events such as proliferation, differentiation, cytoskeletal organization, and vesicular 
trafficking (Y. Li and Hu 2011). The superfamily of small GTPases is divided into five major 
subfamilies based on sequence similarity and functional homology (i.e. Ras, Rho, Rab, Arf/Arl, 
and Ran) (Weenerberg et al., 2005). These versatile proteins use a functional switching process 
that depends upon GTP hydrolysis to cycle between the GTP-bound “active” and GDP-bound 
“inactive” states, similar to heterotrimeric G proteins. The crucial aspect of their function in 
many processes is that the modulation of the “active” and “inactive” states is dependent upon the 
presence or absence of particular regulatory proteins that in some cases are required for the 
cycling (reviewed in Cherfils and Zeghouf 2013). Guanine nucleotide exchange factors (GEFs) 
facilitate the exchange of GDP for GTP and therefore activation, while GTPase activating 
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proteins (GAPs) stimulate GTP hydrolytic activity of the small GTPase (reviewed in Cherfils 
and Zeghouf 2013). These modulators only activate or inactivate small GTPases in a specific 
context making them ideal for regulating complex protein-protein interactions as well as 
generating and maintaining membrane identity. These processes are especially important in 
photoreceptor neurons, which require complicated protein interactions in specific intracellular 
compartments, such as the connecting cilium or OS. Most proteins in the OS localize to a 
specific location such as the connecting cilium, the disc membrane or the plasma membrane, 
thereby requiring the trafficking to be highly selective. This exemplifies the typical scenario of 
small GTPase function, where it is active in one compartment, (e.g. the outer segment) and 
inactive in another (e.g. inner segment). 
 Modulation of a given small GTPase’s guanine nucleotide binding state are just one 
component of its cellular functionality. Many of these proteins are highly homologous and share 
multiple domains that are conserved. These domains are related to the general small GTPase 
function as a molecular switch, while the remaining sequence determines the cellular processes 
that it may be involved in by dictating its effector proteins of localization. Some proteins can 
have very high protein sequence identity/similarity and share many of the same interacting 
partners, yet have different functions (e.g. ARL3 and ARL2). For example, ARL3 and ARL2 
proteins have 53% identity in primary sequence and a high degree of structural similarity yet 
serve different roles in multiple cells lines. Specifically, ARL3 loss results in failure of 
cytokinesis and an increase in acetylated-α-tubulin, while in the same cell line, overexpression of 
dominant active ARL2 results in arrest in M phase along with microtubule obliteration (Zhou et 
al. 2006). While these proteins share some interacting proteins such as ARL2BP, TBCD, 
UNC119 (HRG4), and PrBPδ, they also have specific interactors like retinitis pigmentosa protein 
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2 (RP2) (for ARL3) and TBCC (for ARL2) (Burd, Strochlic, and Gangi Setty 2004; Veltel et al. 
2008; Chen et al. 2016). The extent to which these similarities and differences play a role in vivo 
has yet to be determined. This example demonstrates the complexity of the interactions of small 
GTPases and that it requires years or decades of research to tease out the details and sequence of 
events of a given molecular pathway. Here we focus on the on the function of small GTPases in 
photoreceptor cell biology in order to highlight their functional diversity and demonstrate the 
methodology used to tease out molecular mechanisms underlying their function.  
ARF4, RAB8, and RAB11 IN RHODOPSIN TRAFFICKING 
Rhodopsin is capable of capturing photons and altering its conformation to begin an intracellular 
signaling cascade, known as phototransduction. It is a highly abundant 7-transmembrane protein 
with additional post-translational modifications including palmitoylation, phosphorylation, and 
glycosylation (Murray, Fliesler, and Al-Ubaidi 2009). Considering it is the first protein in the 
phototransduction cascade it has been studied extensively with respect to its physiological 
function, as well as the mechanisms involved in localization to its site of function in the OS. It is 
imperative that rhodopsin be selectively localized to the OS; this process requires a complex 
series of protein:protein and protein:lipid interactions regulated by a set of small GTPases. 
Rhodopsin trafficking involves at least three known small GTPases just in its transportation from 
the Golgi apparatus to the photoreceptor cilium. In this complex trafficking process rhodopsin is 
synthesized and processed in the endoplasmic reticulum (ER) and then sent to the Golgi 
apparatus for post-translational modification and sorting to the appropriate membrane 
compartment (J. Wang et al. 2012; Dusanka Deretic and Wang 2012; Dusanka Deretic 2013). 
This process of sorting is regulated by a number of proteins including Arf4, ASAP1, Rab11, 
Rabin8 and Rab8 (J. Wang et al. 2012). These proteins are primarily functional sets of small 
7 
 
GTPases associated with their regulatory counterparts, GAPs and GEFs, which interact 
sequentially to bud rhodopsin-containing vesicles from trans-golgi network (TGN) and transport 
rhodopsin to the photoreceptor connecting cilium.  The initial indication of ARF4 involvement 
was discovered through its interaction with the VXPX domain of rhodopsin which is necessary 
for trans-Golgi vesicle budding process (Dusanka Deretic et al. 2005). Subsequent studies 
demonstrated that upon ASAP1 (the COPI-like adaptor protein and Arf4 GAP) binding, Arf4 is 
inactivated and released, and Rab11 and FIP3 are recruited to regulate budding and sorting of 
rhodopsin-containing vesicles from the trans-Golgi network (TGN) (Mazelova et al. 2009). 
ASAP1 then aids in the recruitment of RAB8-GDP with ASAP1 and eventual formation of the 
Rab11-Rabin8-Rab8 complex with the addition of Rabin8 (the Rab8 GEF) near the basal body 
(Dusanka Deretic and Wang 2012; Hattula et al. 2002; Nachury et al. 2007). Rab8 is critical for 
rhodopsin vesicle passage into the connecting cilium region and fusion of those vesicles (D 
Deretic et al. 1995; Moritz et al. 2001). Further studies showed that Rabin8 GEF activity for 
Rab8 is stimulated by Rab11 binding (Knödler et al. 2010). This is an interesting case of 
divergence from less complex ciliary structures as photoreceptor cells contain an alternative GEF 
protein for Rab8 that is localized to the connecting cilium, that is, retinitis pigmentosa GTPase 
regulator (RPGR) (Murga-Zamalloa et al. 2010; Hong et al. 2001). The reason for this extra layer 
of regulation is unknown and deserves further study. It is possible that Rab8 is used as a 
conserved mechanism for transportation of proteins other than just rhodopsin and RPGR acts as 
the regulator in those scenarios. 
This process was teased out over two decades of research, using multiple models and 
systems; thus providing an excellent example of building an elegant molecular model piece by 
piece. Furthermore, these studies spurred research of other disease-associated ciliary proteins 
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with VXPX motifs in different cell types, such as polycystin-1 and polycystin-2 (Geng et al. 
2006; Ward et al. 2011). This research supports the idea that the rhodopsin transport mechanism 
is conserved for a subset of ciliary proteins because the trafficking machinery in polycystin-1 
trafficking is analogous, including Arf4, ASAP1, Rab11 and Rab6 (Ward et al. 2011). 
Additionally, the molecular pathogenesis underlying multiple blinding disease states can and 
have been ascertained by the mechanisms underlying this model. This complex set of 
interactions demonstrates the versatility of small GTPases involved in the trafficking of a single 
membrane embedded protein. Nonetheless the mechanism underlying the transportation of 
rhodopsin to the OS and final insertion into the disc membrane remains unclear.  
It would be interesting to apply these same study techniques to examine the trafficking of 
other OS proteins. It is likely that the small GTPase interactions are conserved and are also 
responsible for trafficking of other transmembrane proteins (e.g. peripherin, ROM1, etc.). These 
proteins may in fact piggy-back on rhodopsin laden vesicles to their destination or the 
mechanism may involve a subset of common proteins along with unidentified substitutes for 
known proteins that serve some minor differences in regulation of transport. 
ARL3/ARL13B IN THE REGULATION OF PRENYLATED PROTEIN TRAFFICKING 
AND OS FORMATION 
The small GTPase, ADP-ribosylation factor-like 3 (ARL3), was identified as a ciliary protein by 
genomic analysis as well as being implicated in photoreceptor cilia through its discovered 
interaction with RP2, mutations of which result in X-linked retinitis pigmentosa (Avidor-Reiss et 
al. 2004; Bartolini et al. 2002). Very little was known at this time about ARL3 and the Arl family 
of small GTPases in general (Gillingham and Munro 2007). More recently, ARL13b has been 
identified as a potential GEF for ARL3 at the connecting cilium (Gotthardt et al. 2015). 
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Furthermore, ARL13b mutations are associated with a common blinding disease associated 
syndrome called Joubert Syndrome (Miertzschke et al. 2014; Cantagrel et al. 2008). This 
association with cilia sparked research into its functional role in ciliary processes and more 
specifically in the development and associated processes of the modified cilium, the 
photoreceptor cell OS. Although initial research in photoreceptor cells demonstrated primarily 
ciliary localization, further study has indicated that ARL3 is present throughout the entire 
photoreceptor layer including the OS (Grayson et al. 2002; Z. C. Wright et al. 2016). 
Additionally, Arl3 deletion in mice results in cilia-related defects including cyst formation in the 
pancreas, liver, and kidney as well as abnormal photoreceptor development (Schrick et al. 2006). 
Follow-up studies demonstrated that ARL3 appears to play multiple roles throughout the life of 
the photoreceptor cell. The phenotypes associated with ARL3 dysfunction or loss in 
photoreceptor cells are dependent upon the timing of the deletion or loss of ARL3 function. For 
instance, floxed-Arl3 mice expressing retina-specific Cre embryonically demonstrate a similar 
phenotype to that seen in the complete KO mentioned above; that is, impaired development of 
the OS and fast degeneration of photoreceptor cells (Hanke-Gogokhia et al. 2016; Schrick et al. 
2006). However, when Rhop-Cre (expressed at ~P4) is expressed in these mice, photoreceptor 
cells develop normally and have progressive mislocalization of prenylated proteins and delayed 
cell death (Hanke-Gogokhia et al. 2016). Furthermore, expression of a dominant active mutant 
(ARL3-Q71L) under the same Rho promoter results in the progressive mislocalization of 
prenylated proteins to the IS and progressive degeneration with no defect in photoreceptor cell 
development (Z. C. Wright et al. 2016). Surprisingly, our studies also indicated that ARL3 plays 
a role in the process of nuclear migration of photoreceptor cells (Z. C. Wright et al. 2016). 
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Moreover, this nuclear migration phenotype can be seen in the RP2 knockout mouse model (L. 
Li et al. 2013).  
ARL3 and ARL13b in Ciliogenesis 
Unfortunately, the reasons underlying the misdevelopment of the photoreceptor cell OS are 
widely unknown. In contrast to studies in vivo (see above), knockdown ARL3 in mammalian in 
vitro systems only affects transport to the cilium and not ciliary development (Lai et al. 2011). In 
addition, as with other small GTPases there are differences in phenotype associated with how the 
protein is manipulated. For instance, in C. elegans, knockout of the Arl3 gene results in defects 
in trafficking of sensory proteins to the cilium, but no ciliary deformations, while overexpression 
of the dominant active mutant leads to defects in ciliogenesis (Y. Li et al. 2010). Li et al. (2010) 
also implicated coordination between ARL3 and ARL13b (more detail later). They conclude that 
loss of ARL13b results in deformation of cilia in C. elegans and overexpression of dominant 
active ARL3 in these strains produces an additive effect. Additionally, deletion of Arl3 in Arl13b 
knockout strains partially rescues cilia effects. Further studies in C. elegans have demonstrated a 
potential causative relationship for misdevelopment of photoreceptor OS through the role of 
ARL3 in regulation of IFT proteins along with ARL13b (Y. Li et al. 2010).  Although the 
molecular mechanisms are not completely understood, Arl3 may act though a HDAC6 pathway 
to regulate IFT complex integrity to have downstream effects on ciliogenesis (Y. Li et al. 2010). 
Mouse models have further implicated ARL3 and ARL13b in the process of photoreceptor OS 
morphogenesis. As mentioned above, embryonic knockout of Arl3 in photoreceptor cells results 
in aberrant development of OS and early cell death (Hanke-Gogokhia et al. 2016; Schrick et al. 
2006). Similarly, Arl13b-/- mouse embryos exhibit shortened nodal cilia and abnormal axoneme 
structure (Caspary, Larkins, and Anderson 2007). More recent data suggests that ARL13b acts as 
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the GEF of ARL3 (Gotthardt et al. 2015). This is quite pertinent information for the following 
section on the role of these proteins in trafficking to the OS, however, it is difficult to interpret in 
the process of OS development.  
From the data provided in the in vitro systems and non-mammalian systems it is quite 
difficult to build a clear picture of how these proteins contribute to the process of ciliogenesis in 
the setting of photoreceptor cells. A complete understanding of their function in photoreceptor 
cell OS formation will require a more detailed look in in vivo models containing photoreceptor 
cells. For example, assessment of conditional and inducible knockout of Arl13b as well as 
transgenic expression of dominant active ARL13b in mice would provide the foundation for 
further research. These animal models along with a deeper look into the interacting partners of 
ARL3 and ARL13b in photoreceptor cells. Finally, the creation of a heterologous system for 
photoreceptor research would provide breakthroughs in the understanding of the field. 
ARL3 in Prenylated Protein Trafficking 
As stated above, the interacting proteins of each small GTPase determine its cellular role. More 
specifically, the localization of the GEF and GAP determine where and when it interacts with its 
effector proteins. This combined with in vitro data showing the resulting functional outcome of 
these interactions helped produce a new model of protein trafficking in photoreceptor cells. In 
this case ARL3 interacts with RP2 (the ARL3 GAP), ARL13b (the ARL3 GEF), and PrBP6δ 
(the primary ARL3 effector) in the trafficking of PDE6 and other prenylated proteins in the 
phototransduction cascade. RP2 was identified as an interacting protein that binds preferentially 
to the ARL3-GTP bound state (Bartolini et al. 2002; Kühnel et al. 2006).  
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RP2, PrBPδ, and ARL13b proteins were implicated in the transport of PDE6 as well as 
other lipid-modified proteins through PDE6δ (Ismail et al. 2011; Gotthardt et al. 2015). Arl3 was 
found to be an effector protein of RP2 which acts as a GAP thereby inactivating Arl3 (Kühnel et 
al. 2006; Schwarz et al. 2012). The RP2 gene is defective in X-linked RP (Branham et al. 2012), 
and it implied that Arl3 would be left activated. This can be inferred from experiments that show 
a defect in RP2 function results in the same phenotype as a constitutively active Arl3 mutant (i.e. 
always GTP-bound) (Evans et al. 2010). Arl3 is primarily localized to throughout the rod and 
cone photoreceptor layer including the OS with some potentially higher concentrations at the 
connecting cilium (Grayson et al. 2002; Z. C. Wright et al. 2016). From these studies it appears 
that Arl3 plays a role in Golgi cohesion and vesicular transport of proteins to the photoreceptor 
cell connecting cilium (Schwarz et al., 2012). Proteomics using cultured cells and in vitro protein 
binding assays have revealed that Arl3 regulates the binding of some prenylated and 
myristoylated proteins to their corresponding cargo chaperone, i.e. PDE6δ or Unc119. More 
specifically, Arl3 is thought to facilitate the release of Unc119-bound myristoylated proteins 
(e.g. transducin-α (Gα subunit)) and PDE6δ-bound farnesylated proteins (e.g. G-protein coupled 
receptor kinase 1 (GRK1)) (Ismail et al., 2012; Wright et al., 2011). However, similar interacting 
intermediates have yet to be identified in the trafficking of PDE6 to the OS in photoreceptor 
cells. 
Based on the results obtained in recent studies (Hanke-Gogokhia et al. 2016; Houbin 
Zhang et al. 2012; Z. C. Wright et al. 2016; Ismail et al. 2012; Ismail et al. 2011), we have 
developed a mechanistic model of ARL3 function in photoreceptor cell prenylated protein 
trafficking. PDE6, GRK1, and transducin begin their post-translation process with the addition of 
a prenyl group by a specific prenyl transferase. After prenyl addition, these proteins are targeted 
13 
 
to ER to complete the last two steps of prenyl processing, endoproteolysis and methylation, 
which are mediated by ER-membrane bound enzymes. It is likely that PrBPδ and its functional 
homologs can retrieve the prenylated proteins from endomembranes for further transport to the 
destination membrane (e.g. periciliary membrane or OS disc) similar to the proposed transport of 
K-ras from the ER to the plasma membrane (Chandra et al. 2012; Apolloni et al. 2000). After 
activation at the connecting cilium by its proposed GEF ARL13b, ARL3 stimulates release of 
prenylated cargo from PrBPδ. Because ARL13b is thought to be localized at the connecting 
cilium and OS, it suggests that ARL3-mediated release of cargo occurs at those locations. The 
remaining ARL3-PrBPδ complex can then be dissociated after inactivation of ARL3 by RP2, 
which facilitates hydrolysis of GTP to GDP.  
This model was the result of over a decade of research from multiple in vitro to in vivo 
models. Importantly, it only illustrates a portion of the function of ARL13b and ARL3 as these 
proteins appear to have multiple functional roles in photoreceptor cells. In addition, there is a 
discrepancy in the length of time that each of these models produces phenotypes. For example, 
mice lacking PrBPδ retina have much slower degeneration maintaining ~5 photoreceptor nuclear 
layers at six months of age (H Zhang et al. 2007). Compare this to knockout or overexpression of 
dominant active ARL3 at P5 which results in almost complete degeneration by two months (Z. 
C. Wright et al. 2016; Hanke-Gogokhia et al. 2016). These discrepancies imply that ARL3 has 
functionality beyond interacting with PrBPδ. Further studies to solidify this molecular model 
could utilize inducible knockout techniques that delete PrBPδ, ARL3, RP2, or ARL13b in adult 
mouse retina. This would isolate the trafficking phenotype from any artifacts conferred by 
developmental defects of the OS.  
ARL3: Alternative Functions 
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One interesting aspect of small GTPases is the diverse range of functional pathways that they can 
be involved in. ARL3 has a number of proposed pathways and these do not necessarily involve 
interaction with the same proteins. As mentioned above, ARL3-Q71L expression results in the 
altered migration of rod photoreceptor cells (Z. C. Wright et al. 2016). This is interesting because 
there is only a subset of cells that do not migrate into the ONL, but instead remain in the INL. 
This is likely the result of onset of relatively late onset of transgenic ARL3-Q71L expression 
(~P4) after major lamination of the retina is already underway. Additionally, this phenotype was 
observed in RP2 null mice, which demonstrate a subset of mislocalized photoreceptor nuclei in 
the INL although this was not specifically mentioned in the text (L. Li et al. 2013). It would be 
interesting to follow up on this phenotype to determine what specific proteins ARL3 
preferentially interacts with at this stage of development. Notably, depletion of what is thought 
of as the primary effector protein, PrBPδ, in mouse photoreceptor cells does not recapitulate this 
phenotype, suggesting an alternative mechanism of action. This mechanism could potentially 
involve prenylated cargo release (e.g. such as nuclear lamins), but through an unidentified PrBPδ 
homolog. In addition to this molecular function, ARL3 has been identified as a player in the 
regulation of release of dynactin complexes from dynein along with dynein light chain LC8 (M. 
Jin et al. 2014). This study also showed that knockdown of ARL3 by siRNA resulted in 
abnormal mislocalization of dynein, dynactin and organelles that are localized by those proteins. 
Finally, ARL3 has been implicated in maintaining Golgi cohesion and trafficking of IFT-
containing vesicles to the base of the cilium in vitro as well as taking part in a sorting module 
composed of Rabep1, GGA1 and ARL3 that binds to polycytin 1 at the Golgi for trafficking to 
cilia (Kim et al. 2014; Evans et al. 2010).  
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 These data support the conclusion that ARL3 has many potential functions as assessed in 
multiple species and cell lines. However, it appears that the primary functions in photoreceptor 
cells include OS development and trafficking of prenylated proteins. Bearing in mind that 
complete knockout of Arl3 in mice is lethal (Schrick et al. 2006), it is important to consider these 
other functions as potential mechanisms of the pathogenesis underlying the loss of ARL3 in 
other effected organs, such as the liver, kidney, and pancreas.   
ARL2 AND ARLBP IN PHOTORECEPTOR OS DEVELOPMENT 
The ARL3 homolog, ARL2, has recently been implicated in the processes of ciliogenesis and OS 
formation in photoreceptor cells (Davidson et al. 2013). It was found that mutations in ARL2 
binding protein (ARL2BP, a.k.a. Binder of ARL Two (BART)) cause an autosomal-recessive 
form of retinitis pigmentosa. ARL2BP is localized to the basal body and cilium-associated 
centriole of photoreceptor cells as well as the periciliary ridge region (Davidson et al. 2013). As 
suggested by its name, ARL2BP is a major binding protein of ARL2, although the functional 
aspects of this interaction remain unclear. Davidson et al. (2013) has implicated both ARL2BP 
and ARL2 in the process of ciliogenesis by showing that depletion of either by siRNA 
knockdown in ARPE19 cells results in shortened cilia. Additionally, the ARL2BP mutation 
associated with RP, p.Met45Arg amino acid substitution, results in a significant decrease in the 
binding affinity to ARL2, suggesting that loss of this interaction is potentially responsible for the 
RP phenotype in these patients (Davidson et al. 2013). Furthermore, ARL2BP localization to the 
basal body was lost in ARPE19 cell lines after depletion of ARL2 and in patient epithelial cell 
lines with the p.Met45Arg mutation (Davidson et al. 2013). These data suggest that the 
interaction of ARL2 and ARL2BP is necessary for proper localization to the basal body. 
However, it is unclear whether ARL2BP or ARL2 has a major function associated with basal 
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body or centriolar dynamics and whether one or the other is simply necessary for proper 
localization. It is important to note that ARL2 has previously been implicated in processes 
associated with microtubule and tubulin dynamics and these functions appear to be mediated at 
centrosomes where it is localized (Zhou et al. 2006; Mori and Toda 2013; Tian, Thomas, and 
Cowan 2010). More recent studies have teased out a mechanism through which ARL2 may 
affect microtubule dynamics in vivo. Specifically, ARL2-GTP interacts with TBCD and TBCE to 
form the “TBC-DEG” complex which is able to then catalytically manipulate αβ-Tubulin dimers 
driving potentially both biogenesis and degradation of those dimers by modulation of the ARL2 
GTPase activity. It is thought that the high energy needed to dissociate αβ-tubulin dimers or 
release soluble polymerizable αβ-tubulin dimers is supplied by the GTP hydrolysis of ARL2 that 
is facilitated by its GAP tubulin binding cofactor C (TBCC). The conclusion is that ARL2 in 
association with TBC-DEG regulates the soluble pool of α- and β-tubulin and therefore the 
dynamics of microtubules that use that tubulin (Nithiananatham et al. 2015). However, it is 
important to note that ARL2BP does not currently have a proposed role in these models. 
Moreover, in vitro studies have shown that although ARL2BP is colocalized with ARL2 in the 
centrosome, specifically in the pericentriolar matrix (PCM), overexpression or loss of ARL2BP 
does not cause the defects in tubulin polymerization or centrosomal fragmentation that occur 
upon expression of dominant active ARL2-Q70L (Zhou et al. 2006). It should be noted that these 
results are specific to centrosomes and not cilia-associated centrioles. This suggests that 
ARL2BP and ARL2 may have exclusive co-dependent functions in cilia-associated centrioles 
only during specific stages of cell development. In order to understand this interaction in the 
context of the photoreceptor cell basal body, ciliary associated centriole, connecting cilium, and 
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OS, we must characterize their interaction in ciliated cell lines completely as well as determine 
the phenotypes associated with loss in photoreceptor-specific knockouts or transgenic lines.  
 ARL2 versus ARL3 function demonstrates a unique case of divergence of function of 
similar proteins. With 53% sequence identity and 63% similarity as well as a number of common 
binding proteins, it is hard to imagine that they have vastly different functions. However, minor 
differences in the way these proteins interact with their shared binding factors as well as 
interactions with uncommon binding partners likely decide the functional fate. For example, 
ARL3 and ARL2 both interact directly with carrier protein UNC119, which is thought to 
regulate trafficking of myristoylated cargo, however, the outcome of this interaction is different. 
Specifically, binding of ARL3-GTP to an UNC119-Cargo complex results in a conformational 
change in UNC119 that causes release of the cargo. However, using this same experimental 
paradigm ARL2-GTP cannot stimulate release of cargo (K. J. Wright et al. 2011). This 
demonstrates that although similar small GTPases may have common interacting partners and a 
high degree of sequence homology they do not necessarily confer the same functional 
relationship.  
ARL6 IN THE REGULATION OF PHOTORECPTOR CILIUM DEVELOPMENT AND 
PROTEIN TRAFFICKING 
ADP-ribosylation factor-like 6 (ARL6) (a.k.a. BBS3) was the first identified small GTPase 
associated with human ciliopathy. Specifically it is associated with the syndromic disorder 
Bardet-Biedel Syndrome, which is characterized by obesity, cognitive impairment, renal 
dysfunction, polydactyly and retinitis pigmentosa, all related to dysfunction of primary cilia in 
those organs (Chiang et al. 2004; Fan et al. 2004). The Arl6-/- mouse model corresponds to the 
human BBS disease state with ciliary defects and associated phenotypes (Q. Zhang, Nishimura, 
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Seo, Vogel, Morgan, Searby, et al. 2011). Most of the disease causing mutations are clustered 
around the GTP binding region of ARL6 resulting in its inability to effectively bind nucleotides, 
thereby disrupting its cycling state and the ability to bind to and act on effector proteins (Wiens 
et al. 2010). These data led to further studies into the role of ARL6 in cilia function. A number of 
previous results are species specific making it difficult to determine the overall function of ARL6 
in photoreceptor cells. For example, studies in C. elegans suggest that it is involved in ciliary 
sensory function, but not ciliogenesis (Blacque et al. 2004). However, studies in mammalian cell 
systems shows that overexpression of ARL6 can result in disassembly of the cilium (Wiens et al. 
2010). Additionally, there is yet another instance of divergence of phenotype based on the 
method of disrupting the small GTPase where expression of the dominant active ARL6-Q73L 
results in an increase in cilia formation along with an increase in cilia length (Wiens et al. 
2010).In explanation to these differences in observed ARL6 functions, studies of the Arl6 
deletion mouse model demonstrate that ARL6 has phenotypes in common with and unique from 
other BBSome protein mutants (Q. Zhang, Nishimura, Seo, Vogel, Morgan, and Searby 2011).  
 ARL6 interaction with the BBSome has been somewhat difficult to understand simply 
because the BBSome is such a complex protein structure that is not fully understood. The 
BBSome is composed 7 highly conserved BBS subunits BBS1, BBS2, BBS4, BBS5, BBS7, 
BBS8, and BBS9 along with BBIP10 (Nachury et al. 2007; Loktev et al. 2008). ARL6-deficient 
cells maintain an intact BBSome core complex, and therefore ARL6 does not contribute to its 
assembly (Q. Zhang, Nishimura, Seo, Vogel, Morgan, Searby, et al. 2011). However, ARL6 is 
required for the localization of the BBSome to the cilium as well as other ciliary proteins to the 
ciliary membrane (e.g. melanin concentrating hormone receptor 1) (Q. Zhang, Nishimura, Seo, 
Vogel, Morgan, Searby, et al. 2011). Additional mechanistic data suggest that ARL6 activation 
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results in the assembly of a BBSome/ARL6 coat on membrane surfaces, which appears to sort 
proteins for entrance into the cilium (H. Jin et al. 2010). On the other hand, ARL6 appears to be 
a regulator of export of ciliary proteins such as the Hedgehog signaling receptors Patched 1 and 
Smoothened out of the cilium (Q. Zhang, Nishimura, Seo, Vogel, Morgan, Searby, et al. 2011; 
Q. Zhang et al. 2012). Interestingly, new animal studies demonstrate that the BBSome may 
function to either exclude non-OS proteins by an export mechanism as above or possibly by 
preventing entry into the OS (Datta et al. 2015). This provides an indication that the BBSome 
coordinated with proper targeting/function with ARL6 may provide some sort of regulation for 
movement of proteins to the base of the connecting cilium (from the OS) or out of the 
photoreceptor OS in addition to its function of targeting proteins from the IS to the cilium. ARL6 
provides another example of the complexity of small GTPase function and how those functions 
may differ depending on the system or the intracellular context. 
RAB28 IN BLINDING DISEASE 
 RAB28 is a member of the Rab (Ras-related in brain) subfamily of small GTPases. It was 
only recently implicated in photoreceptor function through a genomic analysis in multiple 
families identifying mutations in the RAB28 gene that result in cone-rod dystrophy (Roosing et 
al. 2013; Roosing et al. 2014; Riveiro-Álvarez et al. 2015). Rab GTPases are involved in a wide 
range of cellular processes mostly involving dynamics of vesicle trafficking, vesicle fusion, and 
membrane fission events. However, whether Rab28 plays a role in these processes is yet to be 
determined. Interestingly, Rab28 is the first known blinding-disease associated Rab GTPase that 
is prenylated. Note that Rab28 is localized to the photoreceptor cilium and thus may be involved 
in ciliary transport mechanisms. Other Rab proteins that have similar localization are involved in 
ciliary transport such as Rab8 and Rab11 as well as Rab23. Specifially, Rab23 regulates the 
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turnover of Smo (smoothened) in the cilium (Boehlke et al. 2010). Based on localization data 
and the general role of Rab small GTPases it is possible that Rab28 plays a role in protein 
transport at the connecting cilium whether in the form of vesicle fusion, movement of proteins 
through the cilium, or targeting of proteins to the connecting cilium.  
Elucidating its interacting partners is necessary in identifying the role of Rab28 at the 
photoreceptor connecting cilium. Additionally, dominant active and knockout animal models 
will provide major insight into the functions of this protein. Surprisingly, mutation of this protein 
only causes retinitis pigmentosa with no other observed phenotypes in humans. This suggests 
that it may have photoreceptor specific functions that are separate from other cell types or that 
there are proteins with redundant functions in those cells and not in photoreceptor cells. There 
are small number of examples of mutations in ubiquitously expressed proteins that lead to a 
photoreceptor specific phenotype. One proposed mechanism for this disparity has been attributed 
to alternative splicing that produces protein an isoform that serves a particular purpose in the 
photoreceptor sensory cilium and is unnecessary/or not present for other cell types. BBS8 is a  
potential example of this phenomenon, in which specific mutations result in non-syndromic RP, 
while other mutations result in BBS (Murphy et al. 2015). The mechanisms underlying the 
specific phenotype associated with photoreceptor cells is important to understand to elucidate the 
processes that result in specialization of this primary cilium.  
APPROACHES AND DIRECTIONS FOR FUTURE RESEARCH 
 Photoreceptor research has been a slow process as a result of the difficulties associated 
with primarily studying animal models because of the lack of a heterologous tissue system. Most 
studies of underlying cellular pathways involve basic in vitro experiments determining 
protein:protein interactions and localization that must be correlated with clinical manifestations 
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and phenotypes of animal models. Additionally, these specialized cilia require a high level of 
spatiotemporal regulation of protein trafficking to maintain very distinct compartments. Small 
GTPases are no doubt crucial to this regulation and it is no wonder that an increasing number of 
these molecular switches have been implicated in blinding disease states with photoreceptor cell 
dysfunction. The study of small GTPases is fairly straightforward, as generally the mechanisms 
of these proteins are conserved from cell to cell with the primary differences being the effector 
proteins. Although these processes are often complex, involving many proteins for each step, the 
modes in which the small GTPase can be manipulated in vitro and in vivo allow for a stepwise 
process for analysis of the specific protein of interest. Nevertheless, while there has been 
significant breakthroughs in recent years, small GTPases remain understudied in the realm of 
photoreceptor cell biology.  
The first step in determining the extent to which small GTPases play a role in 
photoreceptor cell function is to obtain a comprehensive list of the pertinent small GTPases. 
Previous studies have attempted to isolate the OS or other compartments in order to identify the 
proteins by mass spectrometry (Liu et al. 2007). However, there are difficulties with this 
approach. One major problem is that it may not capture the proteins involved in ciliary 
development or trafficking because those proteins only function there transiently and do not 
necessarily maintain localization there. For example, small GTPases can possibly be localized to 
all compartments, but only function at the cilium or OS. ARL3 is a great example of this as it is 
found throughout the photoreceptor cell, but appears to function (at least for prenylated protein 
trafficking) in the OS or connecting cilium (Z. C. Wright et al. 2016). Nonetheless, these 
proteomic libraries are a great place to start looking for photoreceptor developmental and 
trafficking related phenotypes associated with manipulation of candidate proteins. Additionally, 
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candidate small GTPases for photoreceptor function can be identified by surveying literature 
focusing on other ciliated cell types with known analogous functions or by screens of candidate 
proteins in RPE cell lines as done previously (Yoshimura et al. 2007). Screening the Arl 
subfamily of small GTPases for ciliary developmental effects similar to Yoshimura et al. (2007) 
would allow provide direction for future research. Screening systems could be designed to test 
specific functional effects resulting from the loss or overexpression of a set of proteins. For 
example, a heterologous high-throughput screening system for identifying small GTPases crucial 
for trafficking of specific photoreceptor proteins would accelerate research dramatically. A 
system like this could utilize known proteins that are localized to cilia in RPE cells for example, 
and manipulate expression of candidate small GTPases in that system.  
 The currently known small GTPases involved in photoreceptor OS biogenesis and 
trafficking are understudied and often have confusing or contradictory data. To extend our 
understanding of these proteins, we must determine the regulators and effectors of the proteins 
and their functions in the photoreceptor cell environment. Simply identifying the GEF or GAP of 
a small GTPase has a great impact on the direction of research and the underlying proposed 
mechanisms of action. For example, the recently identified GEF of ARL3, ARL13b, has helped 
build a clearer mechanism of prenylated phototransduction proteins in photoreceptor cells 
(Gotthardt et al. 2015). Because ARL13b has been found to be localized to the OS and 
connecting cilium, it confirms the expected function of active ARL3 which is to release 
prenylated cargo from their respective prenyl transferase (e.g. PDE6 and PrBPδ) in the proper 
location, i.e. connecting cilium. However, these data are limited in that they are typically 
obtained in vitro and not in photoreceptor cells. It is possible that the proteins that can act as a 
GEF do not do so in vivo and that the GEF in photoreceptor cells is yet to be identified. 
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Additionally, considering the diverse roles that these proteins can play it is possible that they 
have multiple GEF proteins that distinguish the molecular cascade in which they are involved. 
To address this, mouse models targeting function of the GEF protein are necessary to provide 
insight into the effectors function and corroborate previous results.  
 Determining the function of a given small GTPase has major complications as well. First, 
conditional approaches are often necessary as complete knockouts confer embryonic lethality. 
More importantly, another major difficulty is that these proteins can serve multiple functions in 
various processes at different timepoints during development of a specific cell type. For 
example, ARL3 appears to have multiple functions in photoreceptor cells, nuclear migration, 
protein trafficking, and OS development (Z. C. Wright et al. 2016; Hanke-Gogokhia et al. 2016). 
This is an important case because it demonstrates the need to study effects of small GTPase 
dysfunction by manipulating it at different timepoints in photoreceptor development with various 
in vivo techniques. This can be done by utilizing alternative promoters to drive transgenic 
expression of Cre recombinase (for conditional gene knockout) or dominant active/inactive 
mutants. Considering the advent of Crispr-Cas9 genome editing technology, we are able to 
generate new animal models quicker and more cost effectively. With that in mind, studying the 
loss or mutation of these proteins using tamoxifen-inducible conditional mouse models is ideal 
and will provide great insight into their molecular function. Another complication associated 
with overexpression of dominant active mutants is off-target effects. It is possible that these 
mutants will function in molecular pathways that the endogenous protein does not because 




With these complications in mind, it is undoubtedly necessary to use a combinatorial 
approach to study small GTPases. Furthermore, expanding the methods through which we study 
photoreceptor proteins will be crucial in the future for unveiling molecular functions specific to 
this cell type. More specifically, the development of a heterologous system such as an ex vivo 
tissue culture in which ciliary dynamics and protein trafficking can be analyzed in live cells will 
provide breakthroughs in the field. Exploring the role of small GTPases in photoreceptor cells 
will provide insights into the molecular events that give rise to the OS and allow proteins to be 
specifically trafficked to there. This research will be crucial in understanding the pathogenesis 










Apolloni, a, I a Prior, M Lindsay, R G Parton, and J F Hancock. 2000. “H-Ras but Not K-Ras 
Traffics to the Plasma Membrane through the Exocytic Pathway.” Molecular and Cellular 
Biology 20 (7): 2475–87. doi:10.1128/MCB.20.7.2475-2487.2000. 
Avidor-Reiss, Tomer, Andreia M Maer, Edmund Koundakjian, Andrey Polyanovsky, Thomas 
Keil, Shankar Subramaniam, and Charles S Zuker. 2004. “Decoding Cilia Function.” Cell 
117 (4): 527–39. doi:10.1016/S0092-8674(04)00412-X. 
Bartolini, Francesca, Arunashree Bhamidipati, Scott Thomas, Uwe Schwahn, Sally a. Lewis, and 
Nicholas J. Cowan. 2002. “Functional Overlap between Retinitis Pigmentosa 2 Protein and 
the Tubulin-Specific Chaperone Cofactor C.” Journal of Biological Chemistry 277 (17): 
14629–34. doi:10.1074/jbc.M200128200. 
Blacque, Oliver E., Michael J. Reardon, Chunmei Li, Jonathan McCarthy, Moe R. Mahjoub, 
Stephen J. Ansley, Jose L. Badano, et al. 2004. “Loss of C. Elegans BBS-7 and BBS-8 
Protein Function Results in Cilia Defects and Compromised Intraflagellar Transport.” 
Genes and Development 18 (13): 1630–42. doi:10.1101/gad.1194004. 
Boehlke, Christopher, Mikhail Bashkurov, Andrea Buescher, Theda Krick, Anne-Katharina 
John, Roland Nitschke, Gerd Walz, and E Wolfgang Kuehn. 2010. “Differential Role of 
Rab Proteins in Ciliary Trafficking: Rab23 Regulates Smoothened Levels.” Journal of Cell 
Science 123 (Pt 9): 1460–67. doi:10.1242/jcs.058883. 
Branham, Kari, Mohammad Othman, Matthew Brumm, Athanasios J. Karoukis, Pelin Atmaca-
Sonmez, Beverly M. Yashar, Sharon B. Schwartz, et al. 2012. “Mutations in RPGR and 
RP2 Account for 15% of Males with Simplex Retinal Degenerative Disease.” Investigative 
26 
 
Ophthalmology and Visual Science 53 (13): 8232–37. doi:10.1167/iovs.12-11025. 
Burd, Christopher G., Todd I. Strochlic, and Subba R. Gangi Setty. 2004. “Arf-like GTPases: 
Not so Arf-like after All.” Trends in Cell Biology 14 (12): 687–94. 
doi:10.1016/j.tcb.2004.10.004. 
Cantagrel, Vincent, Jennifer L. Silhavy, Stephanie L. Bielas, Dominika Swistun, Sarah E. Marsh, 
Julien Y. Bertrand, Sophie Audollent, et al. 2008. “Mutations in the Cilia Gene ARL13B 
Lead to the Classical Form of Joubert Syndrome.” American Journal of Human Genetics 83 
(2): 170–79. doi:10.1016/j.ajhg.2008.06.023. 
Caspary, Tamara, Christine E. Larkins, and Kathryn V. Anderson. 2007. “The Graded Response 
to Sonic Hedgehog Depends on Cilia Architecture.” Developmental Cell 12 (5): 767–78. 
doi:10.1016/j.devcel.2007.03.004. 
Chandra, Anchal, Hernán E. Grecco, Venkat Pisupati, David Perera, Liam Cassidy, Ferdinandos 
Skoulidis, Shehab a. Ismail, et al. 2012. “The GDI-like Solubilizing Factor PDEδ Sustains 
the Spatial Organization and Signalling of Ras Family Proteins.” Nature Cell Biology 14 
(3). Nature Publishing Group: 329–329. doi:10.1038/ncb2462. 
Chen, Keng, Chwee Tat Koe, Zhanyuan Benny Xing, Xiaolin Tian, Fabrizio Rossi, Cheng 
Wang, Quan Tang, et al. 2016. “Arl2- and Msps-Dependent Microtubule Growth Governs 
Asymmetric Division.” The Journal of Cell Biology 212 (6): jcb.201503047. 
doi:10.1083/jcb.201503047. 
Cherfils, Jacqueline, and Mahel Zeghouf. 2013. “Regulation of Small GTPases by GEFs, GAPs, 
and GDIs.” Physiological Reviews 93 (1): 269–309. doi:10.1152/physrev.00003.2012. 
27 
 
Chiang, Annie P, Darryl Nishimura, Charles Searby, Khalil Elbedour, Rivka Carmi, Amanda L 
Ferguson, Jenifer Secrist, et al. 2004. “Comparative Genomic Analysis Identifies an ADP-
Ribosylation Factor-like Gene as the Cause of Bardet-Biedl Syndrome (BBS3).” American 
Journal of Human Genetics 75 (3): 475–84. doi:10.1086/423903. 
Datta, Poppy, Chantal Allamargot, Joseph S. Hudson, Emily K. Andersen, Sajag Bhattarai, 
Arlene V. Drack, Val C. Sheffield, and Seongjin Seo. 2015. “Accumulation of Non-Outer 
Segment Proteins in the Outer Segment Underlies Photoreceptor Degeneration in Bardet–
Biedl Syndrome.” Proceedings of the National Academy of Sciences 112 (32): E4400–4409. 
doi:10.1073/pnas.1510111112. 
Davidson, Alice E., Nele Schwarz, Lina Zelinger, Gabriele Stern-Schneider, Amelia Shoemark, 
Benjamin Spitzbarth, Menachem Gross, et al. 2013. “Mutations in ARL2BP, Encoding 
ADP-Ribosylation-Factor-like 2 Binding Protein, Cause Autosomal-Recessive Retinitis 
Pigmentosa.” American Journal of Human Genetics 93 (2). The American Society of 
Human Genetics: 321–29. doi:10.1016/j.ajhg.2013.06.003. 
Deretic, D, L a Huber, N Ransom, M Mancini, K Simons, and D S Papermaster. 1995. “Rab8 in 
Retinal Photoreceptors May Participate in Rhodopsin Transport and in Rod Outer Segment 
Disk Morphogenesis.” Journal of Cell Science 108 ( Pt 1: 215–24. 
Deretic, Dusanka. 2013. “Crosstalk of Arf and Rab GTPases En Route to Cilia.” Small GTPases 
4 (2): 70–77. doi:10.4161/sgtp.24396. 
Deretic, Dusanka, and Jing Wang. 2012. “Molecular Assemblies That Control Rhodopsin 
Transport to the Cilia.” Vision Research 75: 5–10. doi:10.1016/j.visres.2012.07.015. 
Deretic, Dusanka, Andrew H Williams, Nancy Ransom, Valerie Morel, Paul A Hargrave, and 
28 
 
Anatol Arendt. 2005. “Rhodopsin C Terminus, the Site of Mutations Causing Retinal 
Disease, Regulates Trafficking by Binding to ADP-Ribosylation Factor 4 (ARF4).” 
Proceedings of the National Academy of Sciences of the United States of America 102 (9): 
3301–6. doi:10.1073/pnas.0500095102. 
Evans, R. Jane, Nele Schwarz, Kerstin Nagel-Wolfrum, Uwe Wolfrum, Alison J. Hardcastle, and 
Michael E. Cheetham. 2010. “The Retinitis Pigmentosa Protein RP2 Links Pericentriolar 
Vesicle Transport between the Golgi and the Primary Cilium.” Human Molecular Genetics 
19 (7): 1358–67. doi:10.1093/hmg/ddq012. 
Fan, Yanli, Muneer a Esmail, Stephen J Ansley, Oliver E Blacque, Keith Boroevich, Alison J 
Ross, Susan J Moore, et al. 2004. “Mutations in a Member of the Ras Superfamily of Small 
GTP-Binding Proteins Causes Bardet-Biedl Syndrome.” Nature Genetics 36 (9): 989–93. 
doi:10.1038/ng1414. 
Geng, Lin, Dayne Okuhara, Zhiheng Yu, Xin Tian, Yiqiang Cai, Sekiya Shibazaki, and Stefan 
Somlo. 2006. “Polycystin-2 Traffics to Cilia Independently of Polycystin-1 by Using an N-
Terminal RVxP Motif.” Journal of Cell Science 119 (Pt 7): 1383–95. 
doi:10.1242/jcs.02818. 
Gillingham, Alison K, and Sean Munro. 2007. “The Small G Proteins of the Arf Family and 
Their Regulators.” Annual Review of Cell and Developmental Biology 23: 579–611. 
doi:10.1146/annurev.cellbio.23.090506.123209. 
Gotthardt, Katja, Mandy Lokaj, Carolin Koerner, Nathalie Falk, Andreas Gießl, and Alfred 
Wittinghofer. 2015. “A G-Protein Activation Cascade from Arl13B to Arl3 and 




Grayson, Celene, Francesca Bartolini, J Paul Chapple, Keith R Willison, Arunashree 
Bhamidipati, Sally a Lewis, Philip J Luthert, Alison J Hardcastle, Nicholas J Cowan, and 
Michael E Cheetham. 2002. “Localization in the Human Retina of the X-Linked Retinitis 
Pigmentosa Protein RP2, Its Homologue Cofactor C and the RP2 Interacting Protein Arl3.” 
Human Molecular Genetics 11 (24): 3065–74. 
Hanke-Gogokhia, Christin, Zhijian Wu, Cecilia D. Gerstner, Jeanne M. Frederick, Houbin 
Zhang, and Wolfgang Baehr. 2016. “Arf-like Protein 3 (ARL3) Regulates Protein 
Trafficking and Ciliogenesis in Mouse Photoreceptors.” Journal of Biological Chemistry 3: 
jbc.M115.710954. doi:10.1074/jbc.M115.710954. 
Hattula, Katarina, Johanna Furuhjelm, Airi Arffman, and Johan Peränen. 2002. “A Rab8-
Specific GDP/GTP Exchange Factor Is Involved in Actin Remodeling and Polarized 
Membrane Transport.” Molecular Biology of the Cell 13 (September): 3268–80. 
doi:10.1091/mbc.E02. 
Hong, Dong Hyun, Guohua Yue, Michael Adamian, and Tiansen Li. 2001. “Retinitis Pigmentosa 
GTPase Regulator (RPGR)-Interacting Protein Is Stably Associated with the Photoreceptor 
Ciliary Axoneme and Anchors RPGR to the Connecting Cilium.” Journal of Biological 
Chemistry 276 (15): 12091–99. doi:10.1074/jbc.M009351200. 
Iannaccone, Alessandro, David Man, Naushin Waseem, Barbara J. Jennings, Madhavi 
Ganapathiraju, Kevin Gallaher, Elisheva Reese, Shomi S. Bhattacharya, and Judith Klein-
Seetharaman. 2006. “Retinitis Pigmentosa Associated with Rhodopsin Mutations: 
Correlation between Phenotypic Variability and Molecular Effects.” Vision Research 46 
30 
 
(27): 4556–67. doi:10.1016/j.visres.2006.08.018. 
Ismail, Shehab a, Yong-Xiang Chen, Mandy Miertzschke, Ingrid R Vetter, Carolin Koerner, and 
Alfred Wittinghofer. 2012. “Structural Basis for Arl3-Specific Release of Myristoylated 
Ciliary Cargo from UNC119.” The EMBO Journal 31 (20). Nature Publishing Group: 
4085–94. doi:10.1038/emboj.2012.257. 
Ismail, Shehab a, Yong-Xiang Chen, Alexandra Rusinova, Anchal Chandra, Martin Bierbaum, 
Lothar Gremer, Gemma Triola, Herbert Waldmann, Philippe I H Bastiaens, and Alfred 
Wittinghofer. 2011. “Arl2-GTP and Arl3-GTP Regulate a GDI-like Transport System for 
Farnesylated Cargo.” Nature Chemical Biology 7 (12): 942–49. doi:10.1038/nchembio.686. 
Jin, Hua, Susan Roehl White, Toshinobu Shida, Stefan Schulz, Mike Aguiar, Steven P. Gygi, J. 
Fernando Bazan, and Maxence V. Nachury. 2010. “The Conserved Bardet-Biedl Syndrome 
Proteins Assemble a Coat That Traffics Membrane Proteins to Cilia.” Cell 141 (7): 1208–
19. doi:10.1016/j.cell.2010.05.015. 
Jin, Mingyue, Masami Yamada, Yoshiyuki Arai, Takeharu Nagai, and Shinji Hirotsune. 2014. 
“Arl3 and LC8 Regulate Dissociation of Dynactin from Dynein.” Nature Communications 
5. Nature Publishing Group: 5295. doi:10.1038/ncomms6295. 
Kim, Hyunho, Hangxue Xu, Qin Yao, Weizhe Li, Qiong Huang, Patricia Outeda, Valeriu 
Cebotaru, et al. 2014. “Ciliary Membrane Proteins Traffic through the Golgi via a 
Rabep1/GGA1/Arl3-Dependent Mechanism.” Nature Communications 5 (May). Nature 
Publishing Group: 5482. doi:10.1038/ncomms6482. 
Knödler, Andreas, Shanshan Feng, Jian Zhang, Xiaoyu Zhang, Amlan Das, Johan Peränen, and 
Wei Guo. 2010. “Coordination of Rab8 and Rab11 in Primary Ciliogenesis.” Proceedings 
31 
 
of the National Academy of Sciences of the United States of America 107 (14): 6346–51. 
doi:10.1073/pnas.1002401107. 
Kühnel, Karin, Stefan Veltel, Ilme Schlichting, and Alfred Wittinghofer. 2006. “Crystal 
Structure of the Human Retinitis Pigmentosa 2 Protein and Its Interaction with Arl3.” 
Structure 14 (2): 367–78. doi:10.1016/j.str.2005.11.008. 
Lai, Cary K, Nidhi Gupta, Xiaohui Wen, Linda Rangell, Ben Chih, Andrew S Peterson, J 
Fernando Bazan, Li Li, and Suzie J Scales. 2011. “Functional Characterization of Putative 
Cilia Genes by High-Content Analysis.” Molecular Biology of the Cell 22 (7): 1104–19. 
doi:10.1091/mbc.E10-07-0596. 
Li, Linjing, Naheed Khan, Toby Hurd, Amiya Kumar Ghosh, Christiana Cheng, Robert Molday, 
John R. Heckenlively, Anand Swaroop, and Hemant Khanna. 2013. “Ablation of the X-
Linked Retinitis Pigmentosa 2 (Rp2) Gene in Mice Results in Opsin Mislocalization and 
Photoreceptor Degeneration.” Investigative Ophthalmology and Visual Science 54 (7): 
4503–11. doi:10.1167/iovs.13-12140. 
Li, Yujie, and Jinghua Hu. 2011. “Small GTPases and Cilia.” Protein Cell 2 (1): 13–25. 
doi:10.1016/j.biotechadv.2011.08.021.Secreted. 
Li, Yujie, Qing Wei, Yuxia Zhang, Kun Ling, and Jinghua Hu. 2010. “The Small GTPases ARL-
13 and ARL-3 Coordinate Intraflagellar Transport and Ciliogenesis.” Journal of Cell 
Biology 189 (6): 1039–51. doi:10.1083/jcb.200912001. 
Liu, Qin, Glenn Tan, Natasha Levenkova, Tiansen Li, Edward N Pugh, John J Rux, David W 
Speicher, and Eric a Pierce. 2007. “The Proteome of the Mouse Photoreceptor Sensory 




Loktev, Alexander V., Qihong Zhang, John S. Beck, Charles C. Searby, Todd E. Scheetz, J. 
Fernando Bazan, Diane C. Slusarski, Val C. Sheffield, Peter K. Jackson, and Maxence V. 
Nachury. 2008. “A BBSome Subunit Links Ciliogenesis, Microtubule Stability, and 
Acetylation.” Developmental Cell 15 (6): 854–65. doi:10.1016/j.devcel.2008.11.001. 
Mazelova, Jana, Lisa Astuto-Gribble, Hiroki Inoue, Beatrice M Tam, Eric Schonteich, Rytis 
Prekeris, Orson L Moritz, Paul a Randazzo, and Dusanka Deretic. 2009. “Ciliary Targeting 
Motif VxPx Directs Assembly of a Trafficking Module through Arf4.” The EMBO Journal 
28 (3): 183–92. doi:10.1038/emboj.2008.267. 
Miertzschke, Mandy, Carolin Koerner, Michael Spoerner, and Alfred Wittinghofer. 2014. 
“Structural Insights into the Small G-Protein Arl13B and Implications for Joubert 
Syndrome.” Biochem. J 457: 301–11. doi:10.1042/BJ20131097. 
Mori, Risa, and Takashi Toda. 2013. “The Dual Role of Fission Yeast Tbc1/cofactor C 
Orchestrates Microtubule Homeostasis in Tubulin Folding and as a GAP for GTPase 
Alp41/Arl2.” Molecular Biology of the Cell 24: 1–29. doi:10.1091/mbc.E12-11-0792. 
Moritz, O L, B M Tam, L L Hurd, J Peränen, D Deretic, and D S Papermaster. 2001. “Mutant 
rab8 Impairs Docking and Fusion of Rhodopsin-Bearing Post-Golgi Membranes and Causes 
Cell Death of Transgenic Xenopus Rods.” Molecular Biology of the Cell 12 (8): 2341–51. 
Murga-Zamalloa, Carlos A., Stephen J. Atkins, Johan Peranen, Anand Swaroop, and Hemant 
Khanna. 2010. “Interaction of Retinitis Pigmentosa GTPase Regulator (RPGR) with 
RAB8A GTPase: Implications for Cilia Dysfunction and Photoreceptor Degeneration.” 
Human Molecular Genetics 19 (18): 3591–98. doi:10.1093/hmg/ddq275. 
33 
 
Murphy, Daniel, Ratnesh Singh, Saravanan Kolandaivelu, Visvanathan Ramamurthy, and Peter 
Stoilov. 2015. “Alternative Splicing Shapes the Phenotype of a Mutation in BBS8 To Cause 
Nonsyndromic Retinitis Pigmentosa.” Molecular and Cellular Biology 35 (10): 1860–70. 
doi:10.1128/MCB.00040-15. 
Murray, Anne R, Steven J Fliesler, and Muayyad R Al-Ubaidi. 2009. “Rhodopsin: The 
Functional Significance of Asn-Linked Glycosylation and Other Post-Translational 
Modifications.” Ophthalmic Genetics 30 (3): 109–20. doi:10.1080/13816810902962405. 
Nachury, Maxence V., Alexander V. Loktev, Qihong Zhang, Christopher J. Westlake, Johan 
Per??nen, Andreas Merdes, Diane C. Slusarski, et al. 2007. “A Core Complex of BBS 
Proteins Cooperates with the GTPase Rab8 to Promote Ciliary Membrane Biogenesis.” Cell 
129 (6): 1201–13. doi:10.1016/j.cell.2007.03.053. 
Nachury, Maxence V, E Scott Seeley, and Hua Jin. 2010. “Trafficking to the Ciliary Membrane: 
How to Get across the Periciliary Diffusion Barrier?” Annual Review of Cell and 
Developmental Biology 26: 59–87. doi:10.1146/annurev.cellbio.042308.113337. 
Nithiananatham, Stanley, Sinh Le, Elbert Seto, Weitao Jia, Julie Leary, Kevin D Corbett, and K 
Jeffrey. 2015. “Tubulin Cofactors and Arl2 Are Cage-like Chaperones That Regulate the 
Soluble Αβ-Tubulin Pool for Microtubule Dynamics.” eLife, no. July: 1–33. 
doi:10.7554/eLife.08811. 
Pearring, Jillian N., Raquel Y. Salinas, Sheila a. Baker, and Vadim Y. Arshavsky. 2013. “Protein 
Sorting, Targeting and Trafficking in Photoreceptor Cells.” Progress in Retinal and Eye 
Research 36. Elsevier Ltd: 24–51. doi:10.1016/j.preteyeres.2013.03.002. 
Petrs-Silva, Hilda, and Rafael Linden. 2013. “Advances in Gene Therapy Technologies to Treat 
34 
 
Retinitis Pigmentosa.” Clinical Ophthalmology 8: 127–36. doi:10.2147/OPTH.S38041. 
Riveiro-Álvarez, Rosa, Yajing (Angela) Xie, Miguel-Ángel López-Martínez, Tomasz Gambin, 
Raquel Pérez-Carro, Almudena Ávila-Fernández, María-Isabel López-Molina, et al. 2015. 
“New Mutations in The\n RAB28\n Gene in 2 Spanish Families With Cone-Rod 
Dystrophy.” JAMA Ophthalmology 133 (2): 133. doi:10.1001/jamaophthalmol.2014.4266. 
Roosing, Susanne, Rob W J Collin, Anneke I den Hollander, Frans P M Cremers, and Anna M 
Siemiatkowska. 2014. “Prenylation Defects in Inherited Retinal Diseases.” Journal of 
Medical Genetics 51 (3): 143–51. doi:10.1136/jmedgenet-2013-102138. 
Roosing, Susanne, Klaus Rohrschneider, Avigail Beryozkin, Dror Sharon, Nicole Weisschuh, 
Jennifer Staller, Susanne Kohl, et al. 2013. “Mutations in RAB28, Encoding a Farnesylated 
Small Gtpase, Are Associated with Autosomal-Recessive Cone-Rod Dystrophy.” American 
Journal of Human Genetics 93 (1). The American Society of Human Genetics: 110–17. 
doi:10.1016/j.ajhg.2013.05.005. 
Rossmiller, Brian, Haoyu Mao, and Alfred S Lewin. 2012. “Gene Therapy in Animal Models of 
Autosomal Dominant Retinitis Pigmentosa.” Molecular Vision 18 (February): 2479–96. 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3472929&tool=pmcentrez&ren
dertype=abstract. 
Schrick, Jeffrey J, Peter Vogel, Alejandro Abuin, Billy Hampton, and Dennis S Rice. 2006. 
“ADP-Ribosylation Factor-like 3 Is Involved in Kidney and Photoreceptor Development.” 
The American Journal of Pathology 168 (4): 1288–98. doi:10.2353/ajpath.2006.050941. 
Schwarz, Nele, Tatiana V. Novoselova, Robin Wait, Alison J. Hardcastle, and Michael E. 
Cheetham. 2012. “The X-Linked Retinitis Pigmentosa Protein RP2 Facilitates G Protein 
35 
 
Traffic.” Human Molecular Genetics 21 (4): 863–73. doi:10.1093/hmg/ddr520. 
Tian, Guoling, Simi Thomas, and Nicholas J. Cowan. 2010. “Effect of TBCD and Its Regulatory 
Interactor Arl2 on Tubulin and Microtubule Integrity.” Cytoskeleton 67 (11): 706–14. 
doi:10.1002/cm.20480. 
Veltel, Stefan, Aleksandra Kravchenko, Shehab Ismail, and Alfred Wittinghofer. 2008. 
“Specificity of Arl2/Arl3 Signaling Is Mediated by a Ternary Arl3-Effector-GAP 
Complex.” FEBS Letters 582 (17): 2501–7. doi:10.1016/j.febslet.2008.05.053. 
Wang, D Y, W M Chan, P O S Tam, L Baum, D S C Lam, K K L Chong, B J Fan, and C P Pang. 
2005. “Gene Mutations in Retinitis Pigmentosa and Their Clinical Implications.” Clinica 
Chimica Acta; International Journal of Clinical Chemistry 351 (1-2): 5–16. 
doi:10.1016/j.cccn.2004.08.004. 
Wang, Jing, Yoshiko Morita, Jana Mazelova, and Dusanka Deretic. 2012. “The Arf GAP ASAP1 
Provides a Platform to Regulate Arf4- and Rab11–Rab8-Mediated Ciliary Receptor 
Targeting.” The EMBO Journal 31 (20). Nature Publishing Group: 4057–71. 
doi:10.1038/emboj.2012.253. 
Ward, Heather H, Ursa Brown-Glaberman, Jing Wang, Yoshiko Morita, Seth L Alper, Edward J 
Bedrick, Vincent H Gattone, Dusanka Deretic, and Angela Wandinger-Ness. 2011. “A 
Conserved Signal and GTPase Complex Are Required for the Ciliary Transport of 
Polycystin-1.” Molecular Biology of the Cell 22 (18): 3289–3305. doi:10.1091/mbc.E11-01-
0082. 
Wiens, Cheryl J., Yufeng Tong, Muneer a. Esmail, Edwin Oh, Jantje M. Gerdes, Jihong Wang, 
Wolfram Tempel, et al. 2010. “Bardet-Biedl Syndrome-Associated Small GTPase ARL6 
36 
 
(BBS3) Functions at or near the Ciliary Gate and Modulates Wnt Signaling.” Journal of 
Biological Chemistry 285 (21): 16218–30. doi:10.1074/jbc.M109.070953. 
Wright, Kevin J., Lisa M. Baye, Anique Olivier-Mason, Saikat Mukhopadhyay, Liyun Sang, 
Mandy Kwong, Weiru Wang, et al. 2011. “An ARL3-UNC119-RP2 GTPase Cycle Targets 
Myristoylated NPHP3 to the Primary Cilium.” Genes and Development 25 (22): 2347–60. 
doi:10.1101/gad.173443.111. 
Wright, Zachary C, Ratnesh K Singh, Ryan Alpino, Andrew F X Goldberg, Maxim Sokolov, and 
Visvanathan Ramamurthy. 2016. “ARL3 Regulates Trafficking of Prenylated 
Phototransduction Proteins to the Rod Outer Segment.” Human Molecular Genetics , no. 
March (March): 1–46. doi:10.1093/hmg/ddw077. 
Yoshimura, Shin Ichiro, Johannes Egerer, Evelyn Fuchs, Alexander K. Haas, and Francis A. 
Barr. 2007. “Functional Dissection of Rab GTPases Involved in Primary Cilium 
Formation.” Journal of Cell Biology 178 (3): 363–69. doi:10.1083/jcb.200703047. 
Zhang, H, S Li, T Doan, F Rieke, P B Detwiler, J M Frederick, and W Baehr. 2007. “Deletion of 
PrBP/delta Impedes Transport of GRK1 and PDE6 Catalytic Subunits to Photoreceptor 
Outer Segments.” Proceedings of the National Academy of Sciences of the United States of 
America 104 (21): 8857–62. doi:10.1073/pnas.0701681104. 
Zhang, Houbin, Ryan Constantine, Jeanne M. Frederick, and Wolfgang Baehr. 2012. “The 
Prenyl-Binding Protein PrBP/δ: A Chaperone Participating in Intracellular Trafficking.” 
Vision Research 75. Elsevier Ltd: 19–25. doi:10.1016/j.visres.2012.08.013. 
Zhang, Qihong, Darryl Nishimura, Seongjin Seo, Tim Vogel, Donald a Morgan, and Charles 
Searby. 2011. “Reveals Common BBS-Associated Phenotypes and Bbs3 Unique 
37 
 
Phenotypes.” Proceedings of the National Academy of Sciences of the United States of 
America 3 (51): 20678–83. doi:10.1073/pnas.1113220108/-
/DCSupplemental.www.pnas.org/cgi/doi/10.1073/pnas.1113220108. 
Zhang, Qihong, Darryl Nishimura, Seongjin Seo, Tim Vogel, Donald A Morgan, Charles Searby, 
Kevin Bugge, Edwin M Stone, Kamal Rahmouni, and Val C Sheffield. 2011. “Bardet-Biedl 
Syndrome 3 (Bbs3) Knockout Mouse Model Reveals Common BBS-Associated Phenotypes 
and Bbs3 Unique Phenotypes.” Proceedings of the National Academy of Sciences of the 
United States of America 108 (51): 20678–83. doi:10.1073/pnas.1113220108. 
Zhang, Qihong, Seongjin Seo, Kevin Bugge, Edwin M. Stone, and Val C. Sheffield. 2012. “BBS 
Proteins Interact Genetically with the IFT Pathway to Influence SHH-Related Phenotypes.” 
Human Molecular Genetics 21 (9): 1945–53. doi:10.1093/hmg/dds004. 
Zhou, Cheng-jing, Leslie Cunningham, Adam Marcus, Yawei Li, and Richard A. Kahn. 2006. 
“Arl2 and Arl3 Regulate Different Microtubule-Dependent Processes.” Molecular Biology 






ARL3 regulates trafficking of prenylated phototransduction proteins to the rod outer 
segment. 
Zachary C. Wright1a, Ratnesh K. Singh1a, Ryan Alpino1a, Andrew F.X. Goldberg2, Maxim 
Sokolov 1a,b,c, and Visvanathan Ramamurthy1a,b,c* 
Departments of a Ophthalmology and b Biochemistry, c Center for Neuroscience, Robert C. Byrd 
Health Sciences Center, 1West Virginia University, Morgantown, West Virginia 26506, USA; 
2Eye Research Institute, Oakland University, Rochester, Michigan, 48309, USA  
*Address Correspondence to: Visvanathan Ramamurthy, West Virginia University Eye Institute, 
One Medical Drive, E-363, Morgantown, WV 26506-9193, Tel: 304 598 6940; Fax: 304-598-






The small GTPase, ADP-ribosylation factor-like 3 (ARL3), has been proposed to participate in 
the transport of proteins in photoreceptor cells. Moreover, it has been implicated in the 
pathogenesis associated with X-linked retinitis pigmentosa (XLRP) resulting from mutations in 
the ARL3 GTPase activating protein, retinitis pigmentosa 2 (RP2). To determine the importance 
of ARL3 in rod photoreceptor cells, we generated transgenic mice expressing a dominant active 
form of ARL3 (ARL3-Q71L) under a rod-specific promoter. ARL3-Q71L animals exhibited 
extensive rod cell death after post-natal day 30 (PN30) and degeneration was complete by PN70. 
Prior to the onset of cell death, rod photoresponse was significantly reduced along with a robust 
decrease in rod phosphodiesterase 6 (PDE6) and G-protein receptor kinase-1 (GRK1) levels. 
Furthermore, assembled phosphodiesterase-6 (PDE6) subunits, rod transducin, and G-protein 
receptor kinase-1 (GRK1) accumulated on large punctate structures within the inner segment in 
ARL3-Q71L retina. Defective trafficking of prenylated proteins is likely due to sequestration of 
prenyl binding protein δ (PrBPδ) by ARL3-Q71L as we demonstrate a specific interaction 
between these proteins in the retina. Unexpectedly, our studies also revealed a novel role for 
ARL3 in the migration of photoreceptor nuclei. In conclusion, this study identifies ARL3 as a 
key player in prenylated protein trafficking in rod photoreceptor cells and establishes the 




Trafficking of proteins to the right destination is crucial for proper functioning of a cell. The 
significance of this process is exemplified by polarized photoreceptor cells in the retina. In 
photoreceptors, proteins are synthesized in the inner segment (IS) and are selectively transported 
to their site of action in the outer segment (OS). In addition, the high rate of protein turnover 
resulting from the renewal of the OS requires an efficient mode of protein movement between 
various compartments in photoreceptor cells. Defective trafficking is a known cause of blinding 
diseases such as retinitis pigmentosa in humans (1, 2). Despite the importance of efficient 
trafficking of proteins in photoreceptor cells, the basic mechanism behind the regulation and 
polarized movement of OS proteins are poorly understood.    
Small GTPases are molecular switches cycling between GTP bound “on” and GDP 
bound “off” states and are known regulators of vesicular trafficking, aiding in the movement of 
proteins and lipids between different cellular compartments. ARL3, a member of the ADP-
ribosylation factor (ARF) family, is one such GTPase that is important for photoreceptor 
development. Absence of ARL3 in a mouse knockout leads to poor development of 
photoreceptor cell OS and rapid degeneration of photoreceptor neurons (3). However, little is 
known about the role of ARL3 in vivo (4). ARL3 was identified as an effector protein of retinitis 
pigmentosa protein 2 (RP2). RP2 acts as a GTPase activating protein (GAP) thereby facilitating 
conversion of active ARL3-GTP to inactive ARL3-GDP, accelerating the intrinsic GTPase 
activity up to 90000-fold (5). Defects in the RP2 gene result in an X-linked form of retinitis 
pigmentosa (XLRP), a very severe form of inherited blindness in males. Mutations in this gene 
account for approximately 7-18% of these XLRP cases (6). Disruption of the RP2 gene likely 
leads to dysregulation of its interacting protein ARL3, maintaining it in an active, GTP-bound 
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state as it would rely solely on its slow intrinsic rate (kcat of 0.007/min) (5, 7, 8). Additionally, 
ARL3 has been implicated in the transport of lipid-modified proteins through its association with 
the lipid-binding proteins, prenyl binding protein δ (PrBPδ; also known as PDE6δ) and the 
PrBPδ homolog Unc119 (also known as HRG4) (9–11). PrBPδ has a lipid binding pocket that is 
exposed in the “open” conformation and inaccessible in the “closed” conformation. Active 
ARL3-GTP (but not the inactive ARL3-GDP) binds to an allosteric site that induces the change 
of PrBPδ to the “closed” confirmation thereby lowering affinity for the prenyl group on an 
effector protein. These in vitro data suggest that ARL3 acts as a release factor for prenylated 
cargo being carried by PrBPδ (10). Related studies have shown that loss of PrBPδ in mice lead to 
defective trafficking of prenylated proteins to rod and cone outer segments (12). More recently, it 
has been shown that RP2 knockout mice exhibit slow progressive retinal degeneration (7, 13) 
associated with mislocalization of prenylated phosphodiesterase 6 (PDE6) and G-protein 
receptor kinase 1 (GRK1) (7). This result has also been recapitulated in RP2 null zebrafish, 
which showed slow degeneration and mislocalization of prenylated proteins (14). Absence of 
RP2 likely leads to overactive ARL3 as the GAP activity is lost. We believe that ARL3 
overactivity is the intermediary that causes the phenotype observed in RP2 mouse models and 
associated human disease.  
The purpose of the present study is to gain insight into the role of ARL3 in rod 
photoreceptor cells. ARL3 dysregulation, i.e. constitutive activation via ARL3-Q71L transgenic 
expression, leads to disrupted trafficking of prenylated proteins, including PDE6, GRK1 and 
transducin. Additionally, we show that active ARL3-Q71L and not ARL3-WT interacts with 




ARL3-Q71L Dominant Active Mutant Transgenic Model Generation 
To determine the role for ARL3 in photoreceptor function, we generated a transgenic animal 
expressing dominant active mouse ARL3-Q71L in rod photoreceptor cells (Fig. 1a). A control 
transgenic line expressing tagged wild type mouse ARL3 (ARL3-WT) was also generated. 
Expression of both wild-type and dominant active ARL3 are under the control of a rhodopsin 
promoter that drives the expression of transgenes as early as post-natal day 4 (PN4) in rod 
photoreceptor cells of the retina (15). Transgenic founders were crossed with 129/SV-E wild-
type mice over at least two generations to ensure consistent transgene inheritance and expression 
prior to analysis. Transgenic negative littermates of ARL3-Q71L mice were used as control 
animals for comparison unless stated otherwise. 
We generated an affinity purified rabbit antibody against mouse ARL3. This antibody 
specifically recognized mouse ARL3 expressed in Human Embryonic Kidney (HEK293) cells 
(compare lanes 1 vs. 2 in Fig. 1b). Immunoblotting using the custom made antibody comparing 
the tagged ARL3-Q71L band (~26 kDa) to the endogenous ARL3 band at ~23 kDa (Fig. 1b; p < 
0.001) revealed 2.5 fold overexpression of mutant Q71L over endogenous ARL3 levels. 
Additionally, an anti-HA antibody was used to confirm the identity of the tagged ARL3-Q71L 
(Fig. 1b (green)). ARL3-Q71L expression was also confirmed by indirect immunofluorescence 
with anti-ARL3 antibody and anti-HA antibody (Fig. 1c). ARL3-Q71L was found throughout 
rod photoreceptor cells from the synapse to the OS similar to endogenous ARL3 localization in 
transgenic negative and transgenic ARL-WT samples (Fig. 1c and Supplementary Fig. 1). 
Because previous study utilizing immunofluorescence microscopy reported ARL3 to be 
primarily located in the photoreceptor’s connecting cilium (16), we investigated the distribution 
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of endogenous ARL3, as well as several other photoreceptor proteins, in serial tangential 
sections of the retina (Fig. 1d).  In this technique, protein detection is based on Western blotting 
(17, 18), which makes it exempt from the tissue fixation artifacts, and it unambiguously 
confirmed that ARL3 is indeed present throughout the entire photoreceptor layer (Fig. 1d, 
sections 1-9). A significant fraction of ARL3 was present in the OS, where it co-localized with 
peripherin/RDS (Fig. 1d, sections 1-2). ARL3 enrichment was also observed in the IS domain 
that harbors mitochondria, which is adjacent to the connecting cilium, as evident from the 
presence of the mitochondrial marker, COX I (Fig. 1d, section 3).  The low spatial resolution of 
this technique, however, did not allow us to conclude whether ARL3 is particularly enriched in 
the connecting cilium.  Overall, immunofluorescence data and serial section analysis suggest that 
transgenic ARL3-Q71L and endogenous ARL3 are found throughout the rod photoreceptor layer 
including the OS.  
Progressive loss of rod photoreceptor function in ARL3-Q71L Mice 
To examine the impact of expressing dominant negative ARL3 on the functioning of 
photoreceptor cells, we performed electroretinography (ERG) starting from PN20. Transgenic 
negative littermate controls show a robust “a” wave indicative of photoreceptor function and “b” 
wave demonstrating an appropriate response from downstream bipolar cells. A similar response 
was observed in animal models expressing ARL3-Q71L at light intensities under both scotopic 
and photopic conditions (Fig. 2a). This result indicates that the initial development and function 
of photoreceptor cells appear unaffected by the expression of ARL3-Q71L.  However, there is a 
progressive loss of rod function and by PN70 scotopic a-wave amplitude is almost completely 
lost with slightly reduced photopic b-wave amplitude (Fig. 2a and b).  
Rod photoreceptor cells degenerate in animals expressing ARL3-Q71L 
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Loss of photoreceptor function at PN70 could be due to photoreceptor cell death or defects in the 
phototransduction cascade. To distinguish these possibilities, we investigated the survival of 
photoreceptor cells by counting the outer nuclei at various ages of retinal development. At PN30, 
when there was a substantial reduction in rod photoresponse (463 ± 9 µV: Tg (-) vs 327 ± 56 µV: 
Tg (+); p = 0.01 Fig. 2b), we observed no significant loss in photoreceptor cells. However, by 
PN70, most of the photoreceptor nuclei was lost in transgenic ARL3-Q71L animals compared to 
controls. The ONL length was measured at superior and inferior regions of the retina and was not 
significantly different at PN30, but was dramatically reduced in transgenic animals by PN70 
(Tg(+) = 2.7 layers and Tg(-) = 10.3 layers; p < 0.001 at all locations, Fig. 2d). 
Normal elaboration of photoreceptor OS in ARL3-Q71L Mice 
The morphology of rod photoreceptor cells, in particular the structure of photoreceptor outer 
segment, was analyzed by light and electron microscopy at PN20, when the ERG responses 
appear normal. Gross morphology using toluidine blue staining on semi-thin sections show 
normal elaboration of photoreceptor OSs (Fig. 3a). The OS length of the rod photoreceptors in 
transgenic animals expressing ARL3-Q71L was comparable to that of transgenic negative 
littermate controls (Supplementary Fig. 2a and 2b; OS length: Tg(+) = 11.54 ± 0.12 µm and Tg(-
) = 11.66 ± 0.10 µm; p = 0.39). However, ultrastructural analysis revealed subtle defects 
including a slight increase in endosome content within the IS (Fig. 3b; white arrowheads) and 
misoriented rod OS discs (Fig. 3c; white arrows). The Golgi apparatus and endoplasmic 
reticulum appear dilated in the retina from ARL3-Q71L transgenic animals (Fig. 3c; Golgi 
apparatus = black arrows and ER = black arrowheads). These data suggest that overall 
development of photoreceptor cell outer segments appears to be relatively normal, however, 
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ultrastructural changes in both rod inner and outer segments are present due to transgenic 
expression of ARL3-Q71L.  
Expression of ARL3-Q71L reduces the levels of prenylated phototransduction proteins 
The decrease in photoreceptor function despite normal morphology at PN30 suggests that 
expression of ARL3-Q71L might affect the levels of proteins that participate in 
phototransduction. In addition, previous in vitro studies suggest a relationship between ARL3 
and prenylated proteins through its regulation of PrBPδ (10, 11). Therefore, we investigated the 
levels of prenylated phototransduction proteins prior to significant degeneration at PN30. 
Prenylated phosphodiesterase catalytic subunits α and β (PDE6αβ) were reduced by ~50% in rod 
photoreceptor cells expressing ARL3-Q71L compared to controls (Fig. 4a and 4b; p< 0.001). 
Similarly, farnesylated G-protein receptor kinase (GRK1) and transducin γ (Tγ) levels in retina 
from ARL3-Q71L animals were reduced by ~40% and ~15%, respectively, compared to controls 
(Fig. 4a and 4b; GRK1 - p = 0.001, Tγ - p = 0.001). It is important to note that GRK1 is 
expressed in both rods and cones. Since our animal model expresses ARL3-Q71L exclusively in 
rods, it is likely that the reduction in GRK1 in rods as tested by western blot is an underestimate. 
Additionally, other non-prenylated OS proteins remained unchanged including GC1, rod Tα, and 
rhodopsin (p > 0.05) as well as rod arrestin (data not shown).  
Phosphorylation of activated opsin mediated by GRK1 is necessary for the recovery of 
photoresponses following a flash of light (19–21). In order to determine if there is a functional 
loss of GRK1, scotopic double flash (recovery) experiments were done that involve dark-
adapting the animal and subsequently administering two sequential low intensity (-1.6 Log cd 
s/m2) flashes (the test flash and the probe flash) with various delays between the two flashes. 
This provides insight into how quickly rod photoreceptors can recover to produce the same 
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response as the test flash. As expected from the reduction in GRK1, recovery of scotopic a-wave 
was reduced in ARL3-Q71L mice at PN20 compared to controls (Fig. 4c). The scotopic a-wave 
was completely recovered (i.e. probe flash = test flash) after a 1500 ms in ARL3-Q71L animals 
compared to controls in which complete recovery occurred at a 1000 ms delay (Fig. 4c). Overall, 
these data demonstrate that ARL3-Q71L expression results in a specific reduction in prenylated 
proteins that more severely affects PDE6 and GRK1 than Tγ but does not affect other non-
prenylated OS proteins.  
Loss of rod GRK1 and mislocalization of PDE6 in ARL3-Q71L mice 
After verifying that transgenic expression of ARL3-Q71L caused a specific effect on prenylated 
protein levels, the localization of those proteins was assessed by immunofluorscence microscopy 
at PN25 prior to significant cell death. Two distinct defects were noted with respect to different 
prenylated proteins. In agreement with our results from immunoblotting, we found a marked 
reduction in immunoreactivity for GRK1 in the rod OS in transgenic ARL3-Q71L animals. As 
expected, expression of GRK1 in cone outer segments was unaffected (Fig. 5a). Interestingly, 
transgene expression resulted in mislocalization of PDE6 subunits, and to a lesser extent 
transducin, to the inner segment in large punctate structures (Fig. 5a-e). Similar to our Tg(-) 
littermate controls, immunoreactivity of PDE6β in Tg(+) ARL3-WT was exclusively found in 
the OS (Supplementary Fig. 1). In addition, other non-prenylated OS proteins were properly 
localized with comparable intensity, including cyclic nucleotide gated channel α1 (CNGA1) 
(Fig. 5b-e) and peripherin (Fig. 5a) as well as rhodopsin and GC-1 (data not shown). 
Furthermore, the punctate structures with immunoreactivity for PDE6 and transducin 
progressively accumulate with age (Fig. 6a-b). This accumulation of PDE6 in the IS corresponds 
to a decrease in levels of PDE6 in OS. Additionally, the PDE6 found in these structures is likely 
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assembled as it was identifiable with the anti-ROS1 antibody, which is known to recognize only 
the assembled PDE6 complex (PDE6αβγ) (22). This assembled PDE6αβγ was colocalized on the 
same IS structures as transducin (Fig. 6b). Overall, the data suggest that transgenic expression of 
ARL3-Q71L results in mislocalization and degradation of prenylated OS proteins. 
Accumulation of endosomal vesicles in the retina expressing ARL3-Q71L 
To explore the ultrastructural defects, electron microscopy was performed at PN30 prior to 
significant cell death at which point accumulation of PDE6 in IS was observed. As expected, 
general retinal morphology was maintained as shown by semi-thin sections stained with toluidine 
blue (Fig. 7a). Notably, we observed Muller cell processes extending into the IS through the 
outer limiting membrane (Fig. 7c; Muller cell = MC). Furthermore, endosome-like structures and 
misoriented or disrupted OS along with membranous whorls within the IS were frequently 
observed in PN30 transgenic animals (Fig. 7b and c; top 3 rows; IS membrane whorls = asterisk, 
endosomes = white arrowheads, disrupted OS = white arrow). The endosome-like structures 
tended to be between 1 and 2 µm in diameter, which is comparable to the size of the punctate 
PDE6-containing structures identified by confocal IHC microscopy, suggesting that the 
prenylated proteins may be localized to endosomal compartments (Fig. 7d; PDE6 panel 1 
compared to endosome-like structures (panel 2, 3, 4, 6) and IS membrane whorl (panel 5). 
Additionally, in ARL3-Q71L animals, the frequency of misoriented / disrupted OS membrane 
discs was higher and there were fewer well-oriented outer segments compared to controls likely 
resulting from initial stages of photoreceptor cell death (Fig. 7c, Top Row; white arrows). In 
conclusion, drastic ultrastructural changes were found in ARL3-Q71L mice, including 




PrBPδ interacts with ARL3 in vivo 
To provide mechanistic insight into the defects seen in the ARL3-Q71L transgenic animals, we 
performed co-immunoprecipitation (co-IP) experiments. We utilized the HA tag to pull-down 
ARL3-Q71L protein in retinal lysates from transgenic animals. Based on in vitro binding data, 
we expected that constitutively active ARL3-Q71L would trap PrBPδ, and thus disable it (10, 
23). Here, we have for the first time shown that ARL3-Q71L co-immunoprecipitates PrBPδ in 
vivo while transgenic tagged ARL3-WT does not (Fig. 8). Moreover, we show that PDE6 does 
not interact with ARL3-Q71L or ARL3-WT (Fig. 8). This indicates that when ARL3-Q71L is 
bound to PrBPδ it does not bind PDE6, which is consistent with previous studies suggesting that 
ARL3 causes release of prenylated cargo like PDE6 (24).  
Defective rod photoreceptor cell migration in ARL3-Q71L retina 
The retina is normally laminated such that the ONL contains only rod and cone photoreceptors 
and the INL consists of downstream neurons (e.g. bipolar cells). Unexpectedly, we observed a 
defect in rod photoreceptor cell migration in ARL3-Q71L expressing retina. The migration 
defect was uniformly observed across the retina (Data not shown). More specifically, a fraction 
of rod photoreceptor cells, indicated by HA (red) and PDE6 (green) staining, were located in the 
INL/OPL in adult tissues (Fig. 9a-b). DAPI staining further confirms the identity of these cells as 
chromatin of rod photoreceptor cells are distinctly more dense compared to downstream neurons 
(25, 26). It should be noted that there was varying severity between different founder lines and 
the severity of the defect corresponded to the level of transgenic protein expression. Overall, 




Regulation and rapid movement of proteins from the photoreceptor inner to outer segment is a 
poorly understood process and is of clinical significance as defects in this protein trafficking lead 
to blindness. Due to changes in conformation dependent on nucleotide binding, small GTPases 
are ideally suited for polarized movement of proteins. In this study, we examined the role of 
ARL3, a small GTPase, in the trafficking of proteins to the rod photoreceptor outer segment 
(OS). In addition, mutation or depletion of RP2 associated with XLRP in humans likely results in 
excess active (GTP-bound) ARL3, similar to the animal model described in this study (7, 13). 
Therefore, our animal model is also useful in understanding the pathogenesis underlying the 
defects in RP2-associated diseases. In the current study, we show that expression of 
constitutively active ARL3 (ARL3-Q71L) results in progressive loss of function and 
degeneration of rod photoreceptor cells. The decline in photoreceptor function was accompanied 
with progressive accumulation of prenylated PDE6 and transducin in IS. Moreover, levels of 
farnesylated GRK1 were dramatically reduced. Our study establishes the role of ARL3 in 
trafficking and stability of prenylated proteins in rod photoreceptor cells.  
Importantly, the phenotypes associated with ARL3-Q71L were specific to ARL3 function 
and not a result of overexpression or transgene insertion as the loss of photoreceptor function 
corresponded to the level of ARL3-Q71L expression between multiple independent founder lines 
(Supplementary Fig. 3). The number of PDE6 containing vesicles in the IS also corresponded to 
the level of transgene expression (Tg(+++) – 11.4 ± 0.9 vesicles/1000 μm2 and Tg(++) – 2.8 ± 
0.2 vesicles/1000 μm2; p = 0.01; data not shown). In addition, the defects observed in ARL3-
Q71L animals were specific as these were not observed in transgenic animals expressing ARL3-
WT (Supplementary Fig. 1) or ARL2-Q70L (unpublished data). 
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Prior to degeneration, we observed no changes in levels or localization of major 
photoreceptor OS proteins except for prenylated proteins in the ARL3-Q71L transgenic animals. 
More specifically, levels of PDE6 and GRK1 were severely decreased while transducin levels 
showed modest reduction at one month old. Immunofluorescence data suggested that these 
prenylated proteins are trafficked normally to the OS initially, but as the animals aged 
mislocalization to the IS became more severe. These prenylated proteins accumulated in punctate 
structures in the IS and the number of these structures increased with age. It should be noted that 
these structures did not colocalize with the Golgi marker, GM130 and therefore are not Golgi 
dilations (unpublished data). TEM analysis showed that ARL3-Q71L expression induced 
endosomal-like structures within the photoreceptor IS, and we hypothesize that misrouted OS 
proteins were packaged within these structures. The size of the fluorescent puncta identified via 
immunofluorescence was estimated between 1 and 2 µm in diameter, which corresponded to the 
large endosomal structures frequently found in the IS of TEM sections (Fig. 7). It is likely that 
prenylated proteins accumulate on the membrane of endosomes due to their lipid modification. 
This assumption is corroborated by immunofluorescence data, which shows large punctate 
structures with staining on the circumference of the spherical structure with absent staining in the 
middle. In addition, staining of these endosomes with the ROS-1 antibody, which recognizes the 
PDE6αβγ complex and not individual subunits, suggests that PDE6 is in fact fully assembled. 
Importantly, assembled PDE6 and rod transducin γ were present on the same puncta within the 
IS and the number of these puncta increased as the animal aged. Altogether, our results suggest 
that these prenylated proteins translocate to the OS via a trafficking pathway that is dependent 
upon proper function of ARL3, and over-activation results in buildup of these proteins in the 
same subcellular compartment that ultimately leads to their degradation.  
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How does ARL3 over-activation result in specific trafficking defects in prenylated proteins? 
We show that active ARL3-Q71L interacts with PrBPδ while ARL3-WT does not. Although the 
PrBPδ homolog, UNC119, has been identified as an interacting partner of ARL3 in vitro (9, 23), 
we do not see this interaction in our system. The reason behind this observation is not clear. It is 
possible that the affinity for UNC119 for ARL3-Q71L is lower and therefore below the detection 
sensitivity in our experimental system. Our results suggest that mistrafficking of prenylated 
proteins is due to the sequestration of PrBPδ as well as its homologs by the dominant active 
ARL3-Q71L. For PrBPδ, this would result in a predominant “closed” conformation and loss of 
the ability to bind prenylated proteins. The mislocalization of prenylated proteins in ARL3-Q71L 
expressing mice is also in agreement with findings from knockout of PrBPδ or RP2, the GAP for 
ARL3 (7, 12, 14).  
Photoreceptor degeneration in this ARL3-Q71L mouse model is rapid and nearly complete 
by PN70. The primary cause of the rapid photoreceptor loss is the ability of ARL3 to sequester 
multiple binding partners including PrBPδ due to defective GTP hydrolysis by ARL3-Q71L. In 
addition to its potential role in prenylated protein trafficking, ARL3 is also thought to participate 
in regulation of dynein motors, Golgi maintenance and vesicle dispersion, and microtubule 
stability (16, 27–32). However, we observed normal trafficking of non-prenylated proteins 
suggesting that dynein motors and microtubules are not affected. A moderate Golgi and ER 
dilation was noted specifically in transgenic animals. We believe this is due to the excessive 
accumulation of prenylated proteins in the endomembrane system as they cannot be properly 
retrieved by PrBPδ or its homologs. Further studies are needed to test this hypothesis.  
Surprisingly, we observed defective migration of a fraction of ARL3-Q71L expressing 
photoreceptor cells. These cells remained in the INL and in the OPL instead of migrating to the 
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ONL. It is likely only a fraction of photoreceptor cells express ARL3-Q71L prior to migration 
since expression under the 4.4 kb rhodopsin promoter is detectable at PN4 (15) while the 
majority of photoreceptor nuclei have migrated to the outer layer by PN6 (33). Interestingly, 
defective migration of nuclei is also present in mice lacking RP2 where ARL3 is thought to be 
overactive (13; refer to Fig. 4). We hypothesize that this migration defect results from instability 
or improper localization of the farnesylated lamins. Depletion of lamins results in 
neurodevelopmental phenotypes, including a severe defect in neuronal migration and nuclear 
abnormalities such as blebs and elongation (34, 35). Similarly, we observed blebs in the nuclear 
envelope (Supplementary Fig. 4). Additionally, it was recently found that PrBPδ interacts with 
lamin B (36). Alternatively, ARL3 has been shown to affect cytokinesis through a microtubule 
function-based mechanism which could ultimately affect proper lamination of photoreceptor 
cells (30). Importantly, ARL3 is ubiquitously expressed throughout different tissues including 
the brain (37), suggesting that it could be involved in the process of neuronal migration in the 
CNS. Disruption of this process results in lethal and non-lethal neurodevelopment defects 
including lissencephaly, epilepsy, schizophrenia and autism (38–41). In conclusion, this novel 
ARL3 function has broad implications in neuronal migration and associated disease, and 
therefore requires further research. 
Based on the results obtained in this study, we have developed a mechanistic model of ARL3 
function in rod photoreceptor cells and how this mechanism goes awry in the presence of a 
dominant active ARL3 mutant (Fig. 10). After addition of a prenyl group by a specific prenyl 
transferase, prenylated proteins such as PDE6, GRK1 and transducin are targeted to ER as the 
last two steps of prenyl processing, endoproteolysis and methylation, are mediated by ER-
membrane bound enzymes. How these prenylated proteins are then moved to the OS from the 
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ER compartment still remains a mystery. Based on our results and previous studies, we believe 
that PrBPδ and its functional homologs can retrieve the prenylated proteins from the ER 
membrane for further transport to the destination membrane similar to the proposed transport of 
K-ras from the ER to the plasma membrane (42, 43). This process must be regulated by ARL3 
such that the proteins are selectively released at the appropriate location. In order for this to 
occur, the recently identified GEF of ARL3, ARL13b (44), must be localized in the area of the 
destination membrane such that ARL3 can be  activated and bind PrBPδ or its homologue 
causing release of the cargo protein, i.e. PDE6, GRK1, or transducin. Interestingly, recent 
research shows that ARL13b localizes to the cilium and OS region (45), which is corroborated 
by our results (Supplementary Fig. 5). This finding suggests that ARL3-mediated release of 
cargo occurs at the cilium or in the OS. Additionally, the ARL3-PrBPδ complex can then be 
acted on by RP2, which facilitates hydrolysis of GTP to GDP thereby inactivating ARL3 and 
causing dissociation and recycling of PrBPδ and its homologues. In our dominant active 
transgenic ARL3-Q71L model, it is likely that this complex remains intact and sequesters PrBPδ 
from its transport cycle of prenylated proteins (Fig. 10b). Disruption of the transport of 
prenylated proteins results in their accumulation in IS and sorting to a degradation pathway.  
Our study sheds light on the process of targeted protein transport and our current model 
shows the importance of ARL3 regulation in trafficking of prenylated phototransduction 
proteins. Finally, we believe our animal model mimics human XLRP resulting from RP2 
mutations that disrupt the small GTPase cycle of ARL3.  
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MATERIALS AND METHODS 
Generation of ARL3-Q71L transgenic mice 
Full-length mouse Arl3 was amplified from a clone purchased from a commercial vendor 
(Thermo Scientific). Using polymerase chain reactions (PCR), we engineered a tandem C-
terminal hemagglutinin (HA) and FLAG fusion tags and subsequently sub-cloned this PCR 
product behind a 4.4 kb rhodopsin promoter (Rhop) (15).  
ARL3-Q71L dominant active mutant was constructed with the full-length tandem tagged 
Arl3 as the template. A mutant oligonucleotide with specific change altering glutamine (Q) at 
position 71 to leucine (L) (WV832: 5’-TCT GAT TTT CCT CAG CCC GCC AAT GTC-3’) was 
used to create the Arl3 mutant with the use of megaprimer directed site-directed mutagenesis 
method. The megaprimer was further extended and amplified using flanking primers containing 
SalI and BamHI restriction sites. The PCR product was then cloned behind 4.4 kb rhodopsin 
promoter using SalI and BamHI restriction sites. All clones selected were sequenced in both 
directions to confirm that there are no unintended mutations.  
The plasmid backbone from clones containing Rhop-Arl3 (wild-type) and Rhop-Arl3 
Q71L (mutant) was removed by digestion with KpnII and NotI enzymes and purified using 
agarose gel electrophoresis followed by elution of the fragment containing Rhop-Arl3 (or Arl3-
Q71L)-polyA. The purified DNA fragment was injected into the pronuclei of oocytes from 
superovulated FVB/N females (WVU Transgenic Animal Core Facilities) and implanted into 
pseudo-pregnant CD-1 females.  
Genotyping and Founder Line Maintenance 
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Wild-type ARL3 (ARL3-WT) and mutant ARL3-Q71L transgenic founders were identified by 
PCR using either genomic DNA prepared from tail or ear punches: (5’ GGA TCG TGA ATC 
AGC CTC TGG CTT 3’; and 5’ TTT CTT CTT TGC GTT GAC ATT CTT GC 3’). All PCR 
reactions were conducted using NEB quick load Taq polymerase with following conditions, 
950C- 2 minutes, 950C- 30 seconds, 590C – 30 seconds, 720C- 45 seconds with last three steps 
repeated for 33 cycles followed by a final extension step of  720C at 5 minutes. Founders were 
backcrossed into wild-type 129/SV-E mice (Charles River) to eliminate the Pde6brd1 mutation 
present in the FVB founders. Removal of rd1 allele was confirmed by PCR genotyping (46). The 
animals were maintained under 12-h light / 12-h dark light cycles with food and water provided 
ad libitum. All experimental procedures involving animals in this study were approved by 
Institutional Animal Care and Use Committee of the West Virginia University. 
Electroretinographic (ERG) analysis 
Mice were dark-adapted overnight prior to testing. Test subject eyes were topically dilated with a 
1:1 mixture of tropicamide:phenylephrine hydrochloride. For ERG testing, mice were placed on 
a heated platform with continuous flow of isoflurane anesthesia through a nose cone (1.5% 
isoflurane with 2.5 liters per minute (lpm) oxygen flow rate). A reference electrode was placed 
subcutaneously in the scalp. ERG responses were recorded from both eyes with silver wire 
electrodes placed on each cornea, with contact being made with a drop of hypromellose solution 
(2% hypromellose in PBS) (Gonioscopic Prism Solution, Wilson Ophthalmic, Mustang, OK, 
USA). Rod dominated responses were elicited in the dark with flashes of LED white light at 
increasing flash intensities. Light-adapted cone responses were elicited with white light flashes 
in the presence of a 30 cd/m2 rod-saturating white background light. ERGs were performed on 
the UTAS Visual Diagnostic System with BigShot Ganzfeld with UBA-4200 amplifier and 
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interface, and EMWIN 9.0.0 software (LKC Technologies, Gaithersburg, MD, USA).  Double 
flash ERG was performed just as above except to flashes were administered at -1.6 LogI for 
scotopic (rod) recovery and 2.4 LogI (under background light as above) for photopic (cone) 
recovery. The recovery (probe) flashes were elicited at variable delays after the initial (test flash) 
(500, 750, 1000, or 1500 ms after the test flash). 
Generation of Antibody against full-length ARL3  
ARL3 protein was purified from pTriex-4 vector expressing a C-terminal his-tagged ARL3 
protein in Origami E.coli strain (Novagen). Origami cells were grown to an OD600 ≈ 0.6 and 
protein production was induced with 1 mM IPTG for 18 hours at 18°C. Finally, the protein was 
purified from IPTG induced E.coli soluble fraction using a Nickel His Affinity Column and 
purified protein was supplied to Pacific Immunology Corp. for generation of the antibody in 
rabbits. The antibody serum was affinity-purified using a GST-ARL3 fusion protein. Purified 
antibody was then tested by western blot and immunofluorescence in HEK 293 cells expressing 
recombinant ARL3 and retinal extracts from animals expressing ARL3.  
Immunoblots 
Mice were euthanized by CO2 inhalation and eyes were enucleated. For immunoblots, flash 
frozen retinal samples were dissected from enucleated eyes and sonicated in phosphate buffered 
saline (PBS: 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4·7H2O, 1.4 mM KH2PO4, with 
protease inhibitor cocktail (Roche)). Protein concentrations were measured using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific, Inc).  Samples were loaded at 150 µg total protein 
per well of a 4-20% gradient polyacrylamide SDS-PAGE resolving gel (Criterion Midi format, 
Bio-Rad), resolved and transferred onto polyvinylidene difluoride membranes (Immunobilon-FL, 
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Millipore, Billerica). Membranes were blocked with western blot blocking buffer (Rockland 
Inc.) for 30 min at room temperature and incubated with the indicated primary antibodies below 
overnight at 4°C. Blots were washed in PBST (PBS with 0.1% Tween-20) 3 times for 5 minutes 
each wash (3 X 5 min) at room temperature and incubated in secondary antibody, goat anti-rabbit 
Alexa 680 (or 800), goat anti-rat Alexa 800, or goat anti-mouse Alexa 680 (Invitrogen) for 30 
min at room temperature. After 3 x 5 minutes of washes with PBST, membranes were scanned 
using the Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA). The 
following primary antibodies were used in this study at a dilution of 1:2000 unless otherwise 
noted: rat anti-HA antibody (Roche), rabbit anti-PDE6α (Pierce), rabbit anti-PDE6β (Pierce), 
rabbit anti-PDE6γ (Pierce), assembled PDE6 (ROS1) (generously provided by Drs. Ted Wensel 
(Baylor College) and Rick Cote (University of New Hampshire), rabbit anti-Transducin-αt1 
(Santa Cruz), mouse anti-cytochrome c oxidase subunit I (COX I) (MS404 MitoSciences), rabbit 
anti-Transducin-γt1 (Santa Cruz), mouse anti-GRK1 (Thermo Fisher), mouse anti-CNGA1 (UC 
Davis/NIH NeuroMab Facility), rabbit anti-RDS-c (Peripherin) (Gabriel Travis, University of 
California, Los Angeles, CA), mouse anti-1D4 (rhodopsin) (gift from Dr. Ted Wensel, Baylor 
Collect of Medicine), and rabbit anti-ARL3 (1:1000) (this work). DAPI (1:1000) (4’,6-
diamindino-2-phenylindole, Invitrogen) and  propidium iodide (PI) (1:2000) (EMD Millipore, 
Billerica, MA, USA) were also used in indirect immunofluorescence. 
Immunoprecipitation (IP) 
Frozen retinas (n=4) from ARL3-Q71L, ARL3-WT, or transgenic negative animals were 
homogenized in 400 µl of 1X PBS containing protease inhibitors and 1 mM iodoacteamide using 
sonication (Fisher Scientific). The homogenized retinal extracts were centrifuged at 10,000 X g 
for 5 minutes and supernatant from this step was used for IP. The supernatant was then incubated 
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for 2 hours with washed anti-HA beads (Roche Biochemicals) at 4°C, followed by three rounds 
of washes with PBS + 0.1% TX-100, one wash with PBS, and final elution with HA peptide at 
37°C for 1 hour. Proteins were then separated by 4-20% gradient SDS-PAGE and immunoblot 
was performed as described above. 
Immunolocalization 
For indirect immunofluorescence studies, enucleated eyes were immersed in 4% 
paraformaldehyde fixative for 5 minutes prior to removal of the anterior segments. Eyecups were 
fixed for an additional 1 hour, washed in PBS for 20 minutes, incubated in 20% sucrose in PBS 
overnight at 4°C. Eyes were then incubated in 1:1 mixture of 20% sucrose in PBS:OCT (Cryo 
Optimal Cutting Temperature Compound, Sakura) for 1 hour, and flash frozen in OCT. 
Cryosectioning was performed with a Leica CM1850 Cryostat, and serial retinal sections of 16 
µm thickness were mounted on Superfrost Plus slides (Fisher Scientific). Retinal sections 
mounted on slides were washed with PBS, and incubated for 1 hour in blocking buffer (PBS with 
5% goat sera, 0.5% TritonX-100, 0.05% sodium azide). Retinal sections were incubated with 
primary antibody at the dilutions indicated below for overnight at 4°C, followed by two 15 
minutes washes with PBS + 0.1% TX-100, and one 10 minutes wash with PBS before incubation 
with secondary antibody at a 1:1000 dilution (DAPI nuclear stain 405, anti-Rat 568, anti-Rabbit 
488 (or 568), anti-mouse 488 (or 568)) for 1 hour. Slides were mounted with ProLong Gold (Life 
Technologies) and cover slipped. Confocal imaging was performed at the WVU Microscope 
Imaging Facility with a Zeiss LSM 510 laser scanning confocal on a LSM Axioimager upright 
microscope using excitation wavelengths of 405, 488, and 543 nm. 
Hematoxylin & Eosin Immunohistochemical Analysis 
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Enucleated eyes were marked at the 12 o’clock position for reference with a red lipophilic dye 
and fixed in Excalibur Pathology Fixation Buffer at room temperature. These fixed whole eyes 
were then sent to Excalibur Pathology (Norman, OK) for paraffin embedding, sectioning at 2 µm 
and H&E staining. The stained sections were then imaged on a Zeiss light microscope. Analysis 
included measuring OS length from 3 different animals at 3 regions ventral and 3 regions dorsal 
to the optic nerve.  
Ultrastructural Analysis 
Enucleated eyes were fixed (2% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M cacodylate 
buffer, pH 7.5) for 30 minutes prior to dissection and removal of the anterior segment and lens, 
and extensively fixed for 48 hours at room temperature. The fixed eyecup was dissected into 6-8 
wedge-shaped pieces. Wedges were dehydrated in a graded ethanol series, and then embedded in 
Polybed 812 (PolySciences, Inc., Warrington, PA, USA). Semi-thin (1 μm) sections were 
collected onto glass slides, stained with toluidine blue, and visualized using a Zeiss Axioimager 
2 microscope equipped with EC Plan-Neofluar 40x (N.A. 0.75) and 100x (1.3 N.A.) objectives. 
Thin sections (ca. 80 nm) from selected wedges were collected onto nickel grids, stained with 
2% uranyl acetate and lead citrate, and imaged using an FEI Morgagni transmission electron 
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Figure 1. ARL3-Q71L Dominant Active Mutant Transgenic Model Generation. A. Scheme 
showing the construct used to express ARL3 in rod photoreceptors cells. The Arl3-Q71L 
(glutamine to leucine) dominant active mutant was expressed under a 4.4 Kb rhodopsin 
promoter. This mutant protein was also C-terminally tagged with FLAG and Hemagglutinin 
(HA). B. Western blot analysis of HEK 293 cells transfected with empty vector or wild-type 
ARL3 (lanes 1 and 2) and retinal lysate from Tg(-) and Tg(+) ARL3-Q71L animals (lanes 3 and 
4). Staining was done with antibodies directed at ARL3 (red) and HA (green) to compare 
expression levels of transgenic vs. endogenous ARL3 (refer to bar graph; p < 0.001). C. Retinal 
sections from Tg(-) and Tg(+) animals stained for ARL3 (green) and CNGA1 (red) (Top and 
Middle Panel) and ARL3 (green) and HA (red) (Bottom Panel) (Scale bar = 10 μm). D. 
Representative immunoblots showing the distribution of ARL3 and other proteins in a set of 
serial tangential 10 µm sections (1-10) of the mouse retina. RDS (perpherin) was used as a rod 
OS marker, COX I was used as a mitochondrial marker present in rod IS and synapse, the α 
subunit of rod transducin (rod Tα) was used as a general rod marker, and β-tubulin was used as a 
general cellular marker. The inset on top, showing a mouse retinal section stained with toluidine 
blue, is provided to illustrate the origin of each section from various cellular compartments of 
rod photoreceptors.   
Figure 2. Progressive loss of rod photoreceptor function and degeneration in ARL3-Q71L 
retina. A. Representative scotopic (rod) and photopic (cone) electroretinograms (ERGs) 
comparing Tg(-) and Tg(+) animals at PN20 and PN70 across multiple light intensities. B. Graph 
illustrating the scotopic a-wave amplitude measured at the light intensity of 0 Log Cd*s/m2 as a 
function of age. C. Retinal sections showing nuclei from Tg(-) and Tg(+) animals stained with 
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propidium iodide at PN30 and PN70. D. Quantification of the ONL length (number of cell 
layers) at different locations within the retina from the inferior to superior portion between Tg(-) 
and Tg(+) animals at PN30 and PN70. * = p < 0.01.  
Figure 3. Normal elaboration of photoreceptor OS in ARL3-Q71L Mice. A. Semi-thin 
sections of Tg(-) and Tg(+) retina from PN20 littermates stained with toluidine blue  (scale bar = 
20 μm). B. Low magnification images from the OS and IS with endosomes indicated by white 
arrowheads (scale bar = 2 μm). C. High magnification ultrastructure of the OS. White arrows 
point to membrane whorls in the rod OS from Tg(+) retina. Dilated endomembranes in the rod IS 
including Golgi apparatus indicated by black arrows and rough endoplasmic reticulum indicated 
by black arrowheads (scale bar = 0.5 μm). 
Figure 4. Expression of ARL3-Q71L reduces the levels of prenylated phototransduction 
proteins. A. Representative immunoblots of PN30 retinal protein samples showing levels of 
prenylated OS proteins and non-prenylated controls. B. Quantification of protein levels from 
Tg(-) and Tg(+) retinal isolates (PDE6β : p = 0.0004, PDE6α : p = 0.009, GRK1 : p = 0.001, Tγ : 
p = 0.001). C. Scotopic double flash (recovery) at PN20 shows the recovery of a-wave amplitude 
at different latencies between flashes from Tg(-) and Tg(+) animals (500 ms – p < 0.002; 750 ms 
– p < 0.001; 1000 ms – p < 0.002; 1500 ms – p = 0.32). * indicates statistically significant 
difference. 
Figure 5. Loss of rod GRK1 and mislocalization of PDE6 in ARL3-Q71L mice. 
Immunolocalization of OS proteins in retinal cross sections at PN25. A. GRK1 (green) 
counterstained with peripherin/RDS (red) in Tg(-) and Tg(+) sections.  B. PDE6β (green) and C. 
PDE6γ (green) each counterstained with CNGA1 (red) in Tg(-) and Tg(+) sections. 
Mislocalization of PDE6β or PDE6γ is indicated by white arrow. Inset in panel B shows a 
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cropped and zoomed image (scale bar = 5 μm) of large punctate structures immunoreactive for 
PDE6 (ranging from 0.5 to 2 μm in diameter) within the inner segment. D. Rod Tα (green) and 
E. Rod Tγ (green) counterstained with CNGA1 (red) in Tg(-) and Tg(+) sections. White arrow 
indicates mislocalized transducin in the IS. 
Figure 6. Progressive accumulation of rod PDE6 and colocalization of assembled rod PDE6 
with GRK1 and transducin. A. Immunolocalization of PDE6β in retinal cross sections of Tg(-) 
and Tg(+) tissues from various ages (PN20-PN50). B. PDE6αβγ (identified by ROS1 antibody), 
rod Tγ (Top Panel: red) immunolocalization in Tg(-) and Tg(+) retinal cross sections at PN50. 
Zoomed image on right illustrates colocalization of PDE6αβγ with Tγ with PDE6αβγ in IS 
punctate structure indicated by white arrow (scale bar = 3 μm). 
Figure 7. Accumulation of endosomal vesicles in the retina expressing ARL3-Q71L. A. 
Semi-thin toluidine stained retinal sections from Tg(-) and Tg(+) animals at PN30 (scale bar = 20 
μm). B. Electron micrographs at low magnification illustrating the structural abnormalities of the 
photoreceptor OS and IS in Tg(+). Littermate Tg (-) serves as the control.  Increased frequency 
of endosomes (white arrowhead), IS membrane whorls (*), and mis-oriented/dysmorphic OS 
discs (white arrow) (scale bar = 5 μm). C. Electron micrographs from Tg(+) retina displaying 
high magnification images of the structures from B. (top 3 rows) as well as dilated Golgi 
apparatus (black arrows) and Muller glial cells extending through the outer limiting membrane 
(MC) (scale bar = 0.5 μm). D. Comparison of immunofluorescent punctate structure with PDE6β 
immunoreactivity on the same scale as the high magnification electron micrographs of the 
abnormal structures in the IS (scale bar = 1 μm).  
Figure 8. PrBPδ interacts with ARL3-Q71L in vivo. Immunoprecipitation (IP) of retinal 
isolates from Tg(-), Tg(+) ARL3-WT (middle), and Tg(+) ARL3-Q71L (right) using rat 
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monoclonal antibody against HA tag. Following IP, immunoblots were probed with indicated 
antibodies. T = Total, U = Unbound, and E = Eluate. 
Figure 9. Defective migration of rod photoreceptor cells in ARL3-Q71L retina. A. Retinal 
cross sections stained for HA (red) and DAPI (blue) comparing Tg(-) littermate and Tg(+) tissues 
at PN25. The zoomed image below was cropped from the white dashed box in the merge image 
above. B. Retinal cross sections stained for rod-specific PDE6β (green) and DAPI (blue) 
comparing Tg(-) and Tg(+) tissues at PN25. The diagram below illustrates the observed 
migration defect in transgenic animals expressing ARL3-Q71L. 
Figure 10. Mechanistic Model for mistrafficking of prenylated proteins in ARL3-Q71L 
mouse. A. After prenylation and further processing, PDE6 and GRK1 are peripherally bound to 
the ER membrane. PrBPδ, or its homologs, extract prenylated proteins from the endomembrane 
and target them to the destination membrane. ARL3 is activated by its GEF (ARL13b) in the 
area of the destination membrane and binds to PrBPδ causing release of PDE6 and/or GRK1. 
RP2 accelerates the GTPase activity of ARL3 stimulating release of PrBPδ from the PrBPδ-
ARL3-GTP complex. B. Exogenously expressed active ARL3-Q71L sequesters PrBPδ and its 
homologs, thereby rendering it in capable of extracting PDE6 from the ER membrane. PDE6 and 
other prenylated proteins buildup in the ER membrane and are pushed out of the ER in 





ARL3 = ADP-Ribosylation Factor-Like 3 
ARL3-Q71L = transgenic dominant active ARL3 
ARL3-WT = transgenic wild-type ARL3 
RP2 = Retinitis Pigmentosa Protein 2 
PDE6 = Phosphodiesterase 6 
PDE6α = phosphodiesterase, alpha subunit 
PDE6β = phosphodiesterase, beta subunit 
PDEγ = phosphodiesterase, gamma subunit 
GRK1 = Rhodopsin Kinase (G-protein receptor kinase 1) 
RP = Retinitis pigmentosa 
XLRP = X-linked recessive retinitis pigmentosa 
DAPI = 4’,6-diamidino-2-phenylindole 
ERG = electroretinogram 
OS = outer segment 
ROS = rod outer segment 
COS = cone outer segment 
IS = inner segment 
RIS = rod inner segment 
CIS = cone inner segment 
ONL = outer nuclear layer 
INL = inner nuclear layer 
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Photoreceptor cells are specialized neurons that contain an elaborate membrane structure, the 
outer segment (OS), associated with a non-motile cilium. Many diseases result in the 
malformation of the OS and these diseases often occur because of an inherited defect in the 
genes involved in ciliogenesis. ADP-ribosylation factor-like 2 (ARL2) has recently been 
implicated in OS formation through its association with ARL2 binding partner (ARL2BP), a 
protein linked to inherited blinding disease. We have developed a transgenic mouse model 
expressing a tagged-dominant active form of human ARL2 (ARL2-Q70L) under a rod-specific 
promoter. Transgenic ARL2-Q70L animals exhibit significant decreased photoreceptor cell 
function as early as post-natal day 16 (P16) and progressive rod degeneration. Furthermore, 
ARL2-Q70L expression results in misdevelopment of inner and outer segments associated with 
mislocalization of rhodopsin. The stunted outer segments are attributed to the observed decrease 
in axonemal length. Additionally, immunofluorescence and ultrastructural analysis revealed 
aberrantly localized photoreceptor cilia at the base of the inner segment. Finally, 
immunoprecipitation revealed interaction of ARL2-Q70L with known tubulin chaperone protein, 
tubulin binding cofactor D (TBCD), suggesting a potential role for tubulin dysregulation in these 
cells. In conclusion, ARL2-Q70L is crucial for photoreceptor neuron sensory cilium 




Photoreceptor neurons utilize the outer segment (OS), a specialized non-motile cilium, to 
efficiently capture and transmit light signal (Pearring et al., 2013). The development of a 
functional OS with stacked membrane discs packed with phototransduction and structural 
proteins depends on cilia formation, i.e. ciliogenesis. A number of diseases result from 
malformation of the OS and these diseases frequently occur because of an inherited defect in the 
genes involved in ciliogenesis. These defects result in blinding disease as well as syndromic 
disorders known as ciliopathies, emphasizing the importance of cilia in development and 
functioning of multiple organs (Goetz and Anderson, 2010; Mockel et al., 2011).  
In order to gain insight into the development of OS and the related diseases, it is crucial 
to identify the proteins involved in this process. Interestingly, there are a number of small 
GTPases, which act as molecular switches, that are believed to play a role in regulating protein-
protein interactions throughout the process of ciliogenesis and OS formation (Li and Hu, 2011; 
Li et al., 2012; Pearring et al., 2013; Zhang et al., 2013). These proteins are likely important for 
temporal and spatial regulation of ciliary proteins, thus adding a level of complexity to the series 
of events necessary for photoreceptor morphogenesis. More specifically, the protein ADP-
ribosylation factor-like 2 (ARL2) has been implicated in the process of OS formation in 
photoreceptor cells through its suspected interaction of the disease-linked gene, ARL2 Binding 
Protein (ARL2BP). Importantly, ARL2, as is the case with many small GTPase effector proteins, 
selectively interacts with ARL2BP in the active state (i.e. ARL2-GTP). ARL2BP is necessary for 
retinal function in humans as mutations in this protein result in the blinding disease, retinitis 
pigmentosa (RP) (Davidson et al., 2013). Moreover, it is hypothesized that ARL2BP-linked RP 
is likely the result of loss of interaction with ARL2. 
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 There is a large gap in knowledge concerning the role of ARL2 in photoreceptor neurons 
as well as in vivo function of this protein in general. Studies of ARL2 and ARL3, an ARL2 
homolog, suggest that they may have overlapping functions. Specifically, they are thought to be 
regulators of prenylated protein trafficking through their interaction with prenylated binding 
protein δ (PrBPδ) (Ismail et al., 2011; Wätzlich et al., 2013). This function of ARL3 has been 
shown in vivo by multiple animal models including dominant active transgenic ARL3-Q71L and 
conditional ARL3 knockout mice (Hanke-Gogokhia et al., 2016; Wright et al., 2016). However, 
a role for ARL2 in prenylated protein trafficking has yet to be tested in vivo.  
Although it has not been specifically identified as a connecting cilium protein in 
photoreceptor cells, ARL2 has been implicated in a number of cellular processes (Kahn et al., 
2005; Zhou et al., 2006; Tian et al., 2010; Ismail et al., 2011; Taniuchi et al., 2011; Newman et 
al., 2014). Specifically, ARL2 is thought to play a role in microtubule formation and regulation 
of the soluble tubulin pool (Bhamidipati et al., 2000; Burd et al., 2004; Zhou et al., 2006; Tian et 
al., 2010; Nithiananatham et al., 2015). A number of studies have shown that expression of 
dominant active ARL2 causes microtubule destruction by preventing polymerization 
(Bhamidipati et al., 2000; Zhou et al., 2006; Tian et al., 2010). More recent studies have shown 
that active ARL2-GTP appears to interact with tubulin binding cofactors D and E (i.e. TBCD and 
TBCE) to form a complex that can regulate the state of tubulin dimerization and therefore the 
pool of free polymerizable tubulin (Nithiananatham et al., 2015). Furthermore, knockdown of 
ARL2 or its binding partner ARL2BP results in shortening of cilia in ARPE-19 cell lines 
(Davidson et al., 2013). Furthermore, it is important to note that ARL2 is localized at the 
centrosome in cell lines where it is proposed to act as a microtubule regulator in an ARL2BP-
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independent manner (Zhou et al., 2006). These data suggest that ARL2 may play a role in 
ciliogenesis by regulating tubulin or ARL2BP at photoreceptor cilium. 
The purpose of this study was to gain insight into the role of ARL2 in rod photoreceptor 
cells by expression of the dominant active mutant ARL2-Q70L. Here we show for the first time 
that proper regulation of ARL2 is necessary for rod ciliogenesis and OS formation. Additionally, 
we show that ARL2 interacts with tubulin binding cofactor D (TBCD), a key player in the 





Endogenous Arl2 Expression Profile and Dominant Active Mutant Transgenic Model 
Generation 
In order to investigate the role of ARL2 in mouse photoreceptor cells, it is important to 
understand the temporal dynamics of Arl2 gene expression. We examined the developmental 
retinal mRNA expression profile of endogenous Arl2 and Arl3 in mice (Figure 1A). Real-time 
PCR was performed in order to quantitate the message levels of these genes at post-natal day 0 
(P0) through P16. As shown in the figure, Arl2 expression remains low until a 4-fold spike in 
message between ages P6 and P9. This “switch” in expression suggests that there is functional 
need for ARL2 corresponding to elaboration of the OS. Arl3 expression showed a similar pattern, 
exhibiting a moderate change in expression at P6-P9. 
To determine the role of ARL2 in photoreceptor function, we generated a transgenic 
animal expressing dominant active human ARL2-Q70L in rod photoreceptor cells (Fig. 1B). 
Expression of ARL2-Q70L is under the control of a rhodopsin promoter (Rhop) that initiates the 
expression of transgenes as early as post-natal day 4 (P4) in rod photoreceptor cells of the retina 
(Song et al., 2014). This approach is similar to our recently published work where we expressed 
ARL3 in rod photoreceptor cells (Wright et al., 2016). Transgenic founders were crossed with 
129/SV-E wild-type mice for a few generations to ensure consistent transgene inheritance and 
expression prior to analysis. Transgenic negative littermates of ARL2-Q70L mice were used as 
control animals for comparison unless stated otherwise. 
We generated an affinity purified rabbit antibody against ARL2. This antibody 
specifically recognized ARL2 and not its homologue ARL3 expressed in Human Embryonic 
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Kidney (HEK293) cells (data not shown). In retina from transgenic animals, we find that ARL2-
Q70L (~23 kDa) was expressed at 40% the level of endogenous ARL2 (~20 kDa) protein (Fig. 
1C; p < 0.001).  Additionally, an anti-HA antibody was used to confirm the identity of the tagged 
ARL2-Q70L (Fig. 1C (green)).  
The expression of transgenic ARL2-Q70L was confirmed by indirect 
immunofluorescence with anti-HA antibody (Fig. 1D). ARL2-Q70L was found in throughout rod 
photoreceptor cells except for the OS. Similar to endogenous ARL2 proteins, we observed 
transgene expression in the photoreceptor connecting cilium (Fig. 1D-E). Unlike ARL3, 
endogenous and transgenic ARL2 are excluded from the rod OS (Wright et al., 2016) (Fig. 1D-
E).  
Overall, these data show a switch in endogenous Arl2 expression between P6 and P9 
coinciding with  the early stages of photoreceptor OS elaboration (Obata and Usukura, 1992) and 
that it is localized primarily to the connecting cilium region.   
Decreased photoreceptor function in ARL2-Q70L mice 
We performed electroretinography (ERG) starting from P16 to determine the impact of 
expression of dominant active ARL2 on rod photoreceptor cell function. Transgenic ARL2-
Q70L animals exhibited a dramatic ~70% reduction in scotopic a-wave at P16 compared to 
transgenic littermate controls which showed a robust a-wave and b-wave (Fig. 2A; Tg(-) = 379.8 
± 7.2 μV and Tg(+) = 120.0 ± 3.3 μV, p < 0.0001). As expected, cone photoreceptor response 
remained unaffected at this time point as transgenic negative and transgenic positive photopic b-
waves were comparable (Fig. 2A; Tg(-) = 123.18 ± 6.4 μV and Tg(+) = 138.2 ± 1.9 μV; p = 
0.17). Rod photoresponse progressively declined in transgenic ARL2-Q70L animals with an 
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85% reduction in a-wave by P100 compared to littermate controls (Fig. 2A-B; Tg(-) = 379.3 ± 
19.6 μV and Tg(+) = 60.7 ± 9.7 μV, p < 0.0001). Finally, only a slight difference rod sensitivity 
was noted with scotopic a-wave half-saturating light intensities of 0.010 ± 0.0019 cd*s/m2 in 
Tg(+) animals versus 0.014 ± 0.0018 cd*s/m2 in littermate controls and calculated maximum a-
wave amplitudes of 225.2 ± 6.6 μV (Tg(+))and 499.7 ± 10.6 μV (Tg(-)) (Supplementary Fig. 1). 
Taken together, these results show that expression of ARL2-Q70L reduced rod photoreceptor 
function that declined over time.   
Rod photoreceptor cells degenerate in animals expressing ARL2-Q70L 
In order to determine if the reduction in photoreceptor function was due photoreceptor cell death, 
we investigated the outer nuclear layer (ONL) length from P13 to P110. At P13, there was no 
difference in the size of the ONL (Fig. 3A-B; Tg(-) = 11.0 layers versus Tg(+) = 10.2 layers; p = 
0.26), however, there was a noticeable increase in the number of apoptotic nuclei observed with 
propidium iodide. At P16 apoptotic nuclei were more frequent with a minor decrease in the ONL 
length. (Fig. 3A, arrows indicate apoptotic nuclei). By P60 there was a major loss of 
photoreceptor cells and by P110 the ONL was nearly gone with only 1-3 nuclear layers 
remaining (Fig. 3A-B; P110: Tg(-) = 10.2 layers and Tg(+) = 2.0 layers; p < 0.01 at all 
locations). These data suggest that defects during development of rod photoreceptor cells results 
in progressive degeneration.  
Reduction of photoreceptor OS proteins ARL2-Q70L animals 
Loss of photoresponse in ARL2-Q70L animals at P16 does not correlate to the minor loss of 
cells at that age. This suggests a defect in phototransduction cascade or a reduction in levels of 
phototransduction proteins. Previous in vitro studies have implicated ARL2 as a regulatory 
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protein for prenylated cargo through its interaction with PrBPδ similar to its homolog ARL3 
(Ismail et al., 2011; Wätzlich et al., 2013). Therefore, we investigated the levels of prenylated 
phototransduction proteins along with other non-prenylated proteins in ARL2-Q70L expressing 
animals prior to degeneration (Fig. 4). The prenylated proteins phosphodiesterase 6 α (PDE6α) 
and β (PDE6β) subunits were significantly reduced by ~30% at P13 compared to transgenic 
negative littermates (PDE6α: P13 ≈ -30% p < 0.001; PDE6β: P13 ≈ -34% p < 0.01). Similarly, 
farnesylated G-protein coupled receptor kinase 1 (GRK1) and rod transducin γ subunit (Gγ1) as 
well as myristoylated rod transducin α (Gαt1) were all significantly reduced at the P13 (GRK1: 
P13 ≈ -17% p < 0.01; Gγ1: P13 ≈ -50% p < 0.01; Gαt1: P13 ≈ -11% p < 0.01). However, to our 
surprise, the non-prenylated OS proteins guanylate cyclase 1 (GC1), rhodopsin, and peripherin 
were all significantly reduced by approximately the same magnitude as the prenylated proteins at 
both P13 (GC1: P13 ≈ -31% p < 0.05; rhodopsin: P13 ≈ -51% p < 0.001; peripherin: P13 ≈ -30% 
p < 0.05). A similar pattern was seen in P16 retinal samples as well (Supplementary Fig. 2). 
These proteins were all normalized to Gαo, which is expressed in the bipolar cells and was 
unchanged between transgenic and littermate controls (P13: p = 0.33). Additionally, tubulin was 
unchanged between transgenic animals and controls (P13: p = 0.99). These results are in contrast 
to mouse models disrupting the ARL2 homolog, ARL3, which result in specific loss of 
prenylated proteins prior to cell death (Hanke-Gogokhia et al., 2016; Wright et al., 2016). This 
pan-decrease in photoreceptor OS proteins suggests that ARL2 is not acting specifically through 
PrBPδ to disrupt prenylated proteins, but is actually functioning through a broader mechanism. 
Abnormal elaboration of photoreceptor OS in ARL2-Q70L Mice 
Because there is a pan-decrease in OS protein levels with no major loss in photoreceptor 
cells at P13, it is likely that there is a structural defect of the OS. For initial insight into 
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photoreceptor cell structure, we examined morphology via light microscopy using toluidine blue 
staining. We completed this at P13 and P16 before ONL degeneration and after initial significant 
photoreceptor loss, respectively. Transgenic ARL2-Q70L had a significant ~2-fold decrease in 
the OS length at P13 (Fig. 5; P13: Tg(-) = 10.9 ± 1.1 μm versus Tg(+) = 4.9 ± 0.5, p < 0.05). 
Furthermore, there was a significant ~1.7-fold decrease in IS length in Tg(+) at P13 (Fig. 5; P13: 
Tg(-) = 12.7 ± 0.1 μm versus Tg(+) = 7.4 ± 0.2 μm, p < 0.001).  Additionally, there were no 
significant differences in ONL length between transgenic negative and positive at P13 (Fig. 5; 
P13: Tg(-) = 53.2 ± 2.7 μm versus Tg(+) = 52.3 ± 1.6 μm, p = 0.79). Similar results were found 
at P16 except there was a minor, but significant reduction in the ONL length at this age. These 
data further support the conclusion that transgenic expression of ARL2-Q70L results in a 
development of photoreceptors.   
Mislocalization of Rhodopsin in ARL2-Q70L animals 
Structural defects in the OS (such as loss of the connecting cilium or decreased OS length) result 
in mislocalization of phototransduction proteins such as rhodopsin (Jiang et al., 2015; Hanke-
Gogokhia et al., 2016). We wanted to determine the effect of stunted OS structure on the 
localization of OS proteins. Additionally, the ARL2 homolog, ARL3, has be shown to regulate 
trafficking of prenylated proteins to the rod OS (Hanke-Gogokhia et al., 2016; Wright et al., 
2016). Therefore, we also wanted to determine if ARL2 serves a redundant function to ARL3 in 
this process. To answer these questions, we examined rod OS proteins using 
immunofluorescence microscopy at P13 and P16 (Fig. 6). Of note, rhodopsin was dramatically 
mislocalized to the ONL surrounding the nuclei as well as the IS and synapse at P13 and P16 in 
ARL2-Q70L animals (Fig. 6 & Supplementary Fig. 3, Panel B). Immunoreactivity for PDE6 and 
rod transducin was also found in the IS, ONL, and synapse similar to rhodopsin albeit to a lesser 
91 
 
extent at P13 and P16 (Fig. 6, Panel A and C and Supplementary Fig. 2, Panel A and C). Finally, 
GRK1 showed normal localization in P13 animals, but exhibited decreased immunoreactivity in 
the rod OS with minor mislocalization at the synapse at P16 (Supplementary Fig. 2, Panel D). 
Unlike opsin, the prenylated proteins GRK1, PDE6, and rod transducin localized normally. Our 
results are also in agreement with previous studies that show that structural defects of the OS 
result in mislocalization of rhodopsin.  
ARL2-Q70L expression results in defects in ciliogenesis and OS development in rod 
photoreceptor cells 
ARL2 has recently been implicated in the regulation of ciliary length in vitro (Davidson et al., 
2013). To explore this potential role in intact photoreceptor cells, immunofluorescence and 
transmission electron microscopy was performed to study axonemal integrity and rod 
photoreceptor cell ultrastructure. Utilizing RP1 and RPGR immunoreactivity the length of the 
connecting cilium and axoneme was measured in P13 ARL2-Q70L retina (Fig. 7A). 
Immunoreactivity of these two markers in control Tg(-) retina was as expected with uniform 
staining generating a clear IS-OS border with 1 to 2 μm connecting cilium extending a 2-4 μm 
axoneme (Fig. 7A; Top Panel). However, in transgenic animals (Tg(+)) the IS-OS border is less 
apparent with a number of instances of cilium staining within the IS region near the outer 
limiting membrane (OLM) (Fig. 7A; Bottom Panel; White Arrows). Although the length of the 
connecting cilium, as measured by RPGR immunoreactivity is comparable to wildtype tissue, the 
length of the axoneme (measured by RP1 immunoreactivity) is dramatically shorter (Fig. 7A; 
Bottom Panel). More specifically, ciliary length in Tg(+) animals was on average ~2-fold shorter 
than littermate controls with approximately 70% of cilia between 1 and 2 μm compared to the 
same proportion between 3 and 4 μm (Fig. 7A; Right).  
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 In order to explore ultrastructural defects, electron microscopy was performed at P13 
when there was an observed decrease in IS and OS length, but prior to significant cell death. 
Photoreceptor OSs were frequently shorter and misoriented in comparison to wildtype controls 
(Fig. 7B-C; White Arrowheads). Additionally, aberrantly localized cilia were found protruding 
from the lower portions of the IS near the OLM (Black Arrows) in the retina from transgenic 
positive animals. In contrast there is a clear demarcation between the inner and outer segment in 
controls (Fig. 7B-C). Similar to our results from light microscopy, the IS was dramatically 
shorter. Overall, these results suggest that expression of ARL2-Q70L significantly disrupts rod 
photoreceptor development and specifically, the development of ciliary axoneme and the OS. 
Tubulin binding cofactor D (TBCD) interacts with ARL2 in vivo 
The photoreceptor axoneme is a microtubule-based organelle that is required for proper cell 
function. Previous studies have shown that ARL2 plays a role in the regulation of the pool of 
tubulin dimers that are available to form microtubules (Nithiananatham et al., 2015). 
Additionally, expression of dominant active ARL2 in vitro causes destruction of microtubules by 
acting on polymerization (Zhou et al., 2006). To provide mechanistic insight into the defects 
seen in the ARL2-Q70L transgenic animals, we performed co-immunoprecipitation (co-IP) 
experiments specifically looking at candidate proteins involved in ARL2-mediated tubulin 
regulation. We utilized the HA tag to pull-down ARL2-Q70L protein in retinal lysates from 
transgenic animals. Based on in vitro binding data, we expected ARL2-Q70L to interact with a 
number of proteins based on previous including ARL2BP, α- and β-tubulin, tubulin binding 
cofactor D (TBCD) and TBCE (tubulin-specific chaperones), and potentially PrBPδ 
(Bhamidipati et al., 2000; Ismail et al., 2011; Davidson et al., 2013; Wätzlich et al., 2013; 
Nithiananatham et al., 2015). Surprisingly, ARL2BP, α-tubulin, and β-tubulin were undetectable 
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in eluates of IP using transgenic lysates. However, TBCD was detected in the ARL2-Q70L 





A full understanding of the components involved in morphogenesis of the rod outer segment is 
lacking. In this study, we have discovered a novel regulator of rod photoreceptor development 
and function, ARL2. Our first indication that ARL2 plays a role in OS morphogenesis was 
endogenous mRNA expression profile, which demonstrates a “switch”-like spike in message 
levels in the retina at approximately P9, a critical period of OS elaboration (Fig. 1A). 
Furthermore, we observed localization of endogenous ARL2 at the connecting cilium via 
immunofluorescence microscopy. In order to study ARL2 in rod photoreceptor neurons, we 
generated a dominant active transgenic mouse model that expresses ARL2-Q70L mutant under a 
rod promoter (Rhop). It should be noted that the expression of our transgene follows a similar 
pattern to expression of native protein with transgenic protein detected at P9 (Wright and 
Ramamurthy, unpublished data). Expression of the transgenic protein was 40% the level of 
endogenous ARL2 and the total amount of ARL2 (transgenic + endogenous) is equal between 
the transgenic positive and transgenic negative animals. With this model, we demonstrate that 
expression of ARL2-Q70L results in early defects in OS development followed by slow 
photoreceptor degeneration.  
We have verified the phenotype in multiple transgenic founder lines that show variable 
levels of severity (Wright and Ramamurthy, unpublished data). Importantly, the phenotype is 
distinct from that of any of the ARL3-Q71L lines generated for previous work (Wright et al., 
2016). Specifically, ARL3-Q71L transgenic animals exhibit normal photoreceptor elaboration 
and function at P20 with a rapid decline in function between ages of P30 and P70 with 
concomitant degeneration of rods by P70. ARL2-Q70L transgenic animals have a decrease in the 
length of the photoreceptor OS and IS as early as P13 and abnormal rod function at P16 with a 
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slow decline and degeneration to P100. Previous studies suggest that ARL2 may act similarly to 
ARL3 as a selective regulator for prenylated protein trafficking (Ismail et al., 2011; Wätzlich et 
al., 2013; Wright et al., 2016). However, we observed minor mislocalization of prenylated 
proteins to the ONL and synapse, and we attribute this mislocalization to stunted OS. This is in 
contrast to ARL3-Q71L transgenic animals, which show progressive mislocalization of PDE6 
and other prenylated proteins with no effect on OS elaboration. Immunoblotting from ARL2-
Q70L retina shows a uniform decrease in the levels of OS proteins and not a selective decrease 
in prenylated proteins as occurs in ARL3-Q71L transgenic retina. Although we cannot 
completely rule out that ARL2 may perform act in prenylated protein trafficking, we can say that 
it does not appear to be its primary role in vivo. These data not only serve as a control for the 
effect of a transgene, but also demonstrate a novel role for ARL2 in rod photoreceptor cells that 
is distinct from its homolog ARL3. 
 Rhodopsin is mislocalized prior to degeneration in ARL2-Q70L retina. Other studies 
have demonstrated that shortening of the OS or loss of the connecting cilium results in 
mislocalization of rhodopsin (Jiang et al., 2015; Hanke-Gogokhia et al., 2016). However, it is 
important to note that knockout and heterozygote mice for rhodopsin result in the absence of or 
shorter OS, respectively (Lem et al., 1999; Frederick et al., 2001; Makino et al., 2012). 
Additionally, mistrafficking of rhodopsin due to transgenic expression of a rhodopsin Pro23His 
mutant results in misdevelopment of the OS and destabilization of OS discs (Olsson et al., 1992; 
Haeri and Knox, 2012). Therefore, it is possible that ARL2 disrupts trafficking of rhodopsin 
thereby affecting OS elaboration. However, the shortening of the IS suggests a different 
mechanism of defective photoreceptor development because knockout of rhodopsin results in 
complete loss of the OS, yet they retain inner segments (Lem et al., 1999). Additionally, ARL2-
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Q70L mice have aberrantly localized cilia that do not seem to be targeted to the distal tip of the 
photoreceptor IS. In either case, it is likely that the slow degeneration of photoreceptors in 
ARL2-Q70L animals results from accumulation and overload of degradation pathways for 
rhodopsin (Frederick et al., 2001; Lin et al., 2007; Price et al., 2011).  
We demonstrate that expression of ARL2-Q70L leads to stunted growth of ciliary 
axoneme. ARL2BP, a known interacting protein of ARL2, may potentially be involved in the 
development of cilia in photoreceptor cells. As previously shown mutation of ARL2BP results in 
retinitis pigmentosa and one specific mutation, c.134T>G (p.Met45Arg), disrupts binding of 
ARL2 (Davidson et al., 2013). Furthermore, knockdown of either ARL2 or ARL2BP results in 
shortening of cilia in RPE cell lines (Davidson et al., 2013). Notably, the active ARL2-GTP (and 
not ARL2-GDP) selectively binds to ARL2BP. Therefore, it is expected that ARL2-Q70L would 
sequester ARL2BP preventing its proper function and resulting in stunted cilia in vivo. Although 
these data suggest a compelling role for ARL2BP in our model, we do not see an interaction 
from immunoprecipitation of transgenic retinal lysates. It is possible that our experimental 
conditions are not sensitive enough or that ARL2BP becomes insoluble after cell lysis and this 
disrupts the interaction with ARL2.  
The photoreceptor cilium is a microtubule based-organelle containing the basal body, 
connecting cilium, and the axoneme, which extends into the OS. This organelle is the foundation 
of the photoreceptor OS and therefore necessary for the specialized function of capturing light. 
Formation of the cilium is complex and is heavily dependent upon the polymerization of tubulin 
to form microtubules and the primary structure of the OS. Interestingly, ARL2 is a known 
regulator of microtubules and tubulin in cell culture systems. And more specifically, expression 
of ARL2-Q70L in multiple cell lines results in destruction of microtubules and cell cycle arrest 
97 
 
(Bhamidipati et al., 2000; Zhou et al., 2006). In addition, expression of wildtype ARL2 rescues 
microtubules from tubulin binding cofactor D (TBCD)-mediated destruction (Bhamidipati et al., 
2000). A similar result was discovered in the adenocarcinoma cell line, MCF7, where lines with 
the greatest expression of ARL2 showed higher content of polymerizable tubulin heterodimers 
and low expressing lines had reduced content (Beghin et al., 2007). A more recent study has also 
implicated ARL2 in the regulation of soluble polymerizable tubulin pools and showed that this 
regulation relies on the formation of a “TBC-DEG” chaperone complex composed of ARL2 and 
the tubulin chaperones TBCD and tubulin binding cofactor E (TBCE), which are proteins 
necessary for tubulin dimer regulation (Nithiananatham et al., 2015). Considering the major 
structural defects associated with ARL2-Q70L expression including dysmorphic OS and IS, it is 
tempting to suggest that ARL2 plays a role in regulation of the polymerizable pool of tubulin in 
photoreceptors. Moreover, we show an interaction with TBCD a component of the “TBC-DEG” 
complex mentioned above. Importantly, ARL2BP does not seem to play a role in tubulin 
regulation, at least outside of its minor effects on ciliary length (Zhou et al., 2006; Newman et 
al., 2014). We conclude from this that ARL2 may constitutively form “TBC-DEG” and disrupt 
the normal regulatory function of the complex. How this dysregulation leads to OS and IS 
dysmophogenesis is unclear and will be the focus of our future study.  
 Finally, we demonstrate the ARL2-Q70L expression results in aberrant localization of the 
photoreceptor cilium. Some of the cases of this phenotype can be explained by impending 
photoreceptor cell death that results in retraction of the OS and IS toward the cell body. 
However, there were many cases where the basal body and axoneme were localized at the base 
of the IS protruding from the cell in different directions. Because the transgene is expressed after 
the point of apical localization of the basal body prior to axoneme elongation, it is likely that 
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extension there is a defect in the process of allow this organelle to remain at the apical surface as 
the IS and OS grows distally. Additionally, we speculate that the defect in axonemal growth is 
required for proper development of the OS and the cells with mislocalized cilia express the 
transgene slightly earlier such that they are unable to produce even a rudimentary OS, which 
results in the growth of the IS over the cilium. Future studies are needed to clarify the role of 
ARL2 in the process of axoneme elongation.   
Major progress has been made in identifying the proteins involved in photoreceptor OS 
development and ciliogenesis and here we have discovered a novel regulator of these processes. 
Furthermore, the current data suggest that expression of ARL2-Q70L results in dysregulation of 
soluble tubulin pools and this dysregulation leads to defects in ciliary development. Our 
conclusions suggest that regulation of tubulin can affect the architecture of photoreceptor cells 
including the spatial organization of the cilia, basal body, and ciliary associated centriole. This 
disruption then results in the misdevelopment of the rod OS and progressive cell death. Future 
studies are necessary to fully elucidate the mechanisms underlying ARL2 regulation of tubulin 




MATERIALS AND METHODS 
RNA isolation and qRT-PCR from retina 
Mouse eyes were enucleated at indicated time points and dissected under microscope (Zeiss 
Stemi DV4) to isolate the retina. RNA was isolated with TRI reagent (Sigma) according to 
manufacturer’s guidelines. Reverse-transcription PCR reactions containing 0.1-0.5 μg RNA were 
primed with Oligo-dT and random hexamers to generate cDNA. Expression of Arl2 and Arl3 
was quantified by SYBR-green qPCR normalized to the expression of Glyceraldehyde-3-
Phoshpate Dehydrogenase (Gapdh). qRT-PCR primers for genes assessed were: Gapdh – 
Forward = AGACGGCCGCATCTTCTT and Reverse = TTCACACCGACCTTCACCAT, Arl3 
– Forward = TACTCCTGGGCTTGGACAAC and Reverse = TGTGACTGCACGCTTTTGAT, 
Arl2 – Forward = GAGCACCGCGGATTCAA and Reverse = 
GCAAAGATGAGGAGGGTTCG. 
ARL2-Q70L transgenic mouse model generation 
Transgenic model generation followed that of previously published work (Wright et al., 2016). 
Briefly, a full-length human ARL2 clone (Thermo Scientific) was used generate an ARL2 mutant 
construct with a tandem C-terminal hemagglutinin (HA) and FLAG tag that is driven by a 4.4 kb 
rhodopsin promoter (Rhop). This ARL2 construct was modified by site-directed mutagenesis to 
produce a glutamine (Q) to leucine (L) variant at position 70 (Q70L) using a mutant 
oligonucleotide (5’-CCG CAG GGA CTT CAG GCC ACC CAC ATC-3’). After amplification, 
the PCR product was modified with a tandem C-terminal HA and FLAG tag and then cloned 
behind a 4.4 kb rhodopsin promoter. All clones selected were sequenced in both directions to 
confirm that there are no unintended mutations. After removal from the plasmid by digestion, 
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Rhop-ARL2-Q70L-polyA was purified by agarose gel electrophoresis and elution. This purified 
DNA fragment was injected into pronuclei of oocytes from superovulated FVB/N females 
(WVU Transgenic Core Facilities) and implanted in to pseudo-pregnant CD-1 females. 
Genotyping and Founder Line Maintenance 
ARL2-Q70L transgenic founders were initially identified by PCR of genomic DNA isolated 
from tail snips or ear punches using the following primers: 5’- GGA TCG TGA ATC AGC CTC 
TGG CTT-3’ and 5’-CTG CAT GCG CTG GCG GTC TGC-3’. PCR reactions utilized NEB 
quick load Taq polymerase with the following conditions: 1. 95°C for 2 minutes, 2. 95°C for 30 
seconds, 3. 59°C for 30 seconds, 4. 72°C for 45 seconds, and 5. 72°C for 5 minutes with steps 2-
4 repeated for 33 cycles. Identified founders were crossed with 129/SV-E mice (Charles River) 
over multiple generations to eliminate the Pde6brd1 mutation present in FVB mice (verified by 
PCR genotyping (Giménez and Montoliu, 2001)) as well as ensure transgenic expression was 
resulting from a single locus. Animals were maintained under a 12-hour light/12-hour dark 
cycles with food and water ad libitium. All experimental procedures in this study were approved 
by the Institutional Animal Care and Use Committee of West Virginia University. 
Electroretinographic (ERG) analysis 
Electroretinography (ERG) was performed as previously using UTAS Visual Diagnostic System 
with BigShot Ganzfeld with UBA-4200 amplifier and interface, and EMWIN 9.0.0 software 
(LKC Technologies, Gaithersburg, MD, USA) (Wright et al., 2016). After dark-adaptation 
overnight, a 1:1 mixture of tropicamide:phenylephrine hydrochloride was used to dilate the test 
animal’s eyes. Mice were placed on a heated platform with continuous flow of 1.5% isofluorane 
with 2.5 liters per minute oxygen flow rate and a subcutaneous reference electrode. Corneal 
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electrodes were placed making contact with the cornea using hypromellose solution (2% 
hypermellose in PBS) (Gonioscopic Prism Solution, Wilson Ophthalmic, Mustang, OK, USA). 
Scotopic responses were measured by exposure to flashes of white LED light starting at low 
intensities and proceeding to higher intensities. Afterward, mice were light-adapted for 10 
minutes under 30 cd/m2 rod-saturating white background light for phototopic response 
measurement. ERGs 
Generation of Antibody against full-length ARL3  
ARL2 antibody was completed as previously (Wright et al., 2016). Briefly, ARL2 with a C-
terminal his-tag was expressed in Origami E.coli strain (Novagen). Origami cells were grown to 
an OD600 ≈ 0.6 and protein production was induced with 1 mM IPTG for 18 hours at 18°C. The 
protein was purified from the soluble fraction using a Nickel His Affinity Column and the eluate 
was supplied to Pacific Immunology Corp. for generation of the antibody in rabbits. Antibody 
serum was then purified against a GST-ARL2 fusion protein and was then tested via western blot 
and immunofluorescence microscopy in HEK 293 cells expressing ARL2 and retinal extracts.  
Immunoblots 
Flash frozen dissected retinal samples from enucleated eyes were sonicated in phosphate 
buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4·7H2O, 1.4 mM KH2PO4, 
with protease inhibitor cocktail (Roche)). After measurement of protein concentration using 
spectrophotometry (NanoDrop - Thermo Fisher Scientific, Inc), a sample volume equal 150 µg 
total protein was loaded per well of a 12% or 15% polyacrylamide SDS-PAGE resolving gel 
(Criterion Midi format, Bio-Rad). Proteins were then resolved and transferred onto 
polyvinylidene difluoride membranes (Immunobilon-FL, Millipore, Billerica). Membranes were 
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blocked for 30 minutes at room temperature (Western Blot Blocking Buffer – Rockland Inc.) and 
incubated with primary antibodies at a dilution of 1:2000 overnight at 4°C. After washing in 
PBST (PBS with 0.1% Tween-20) 3 times for 5 minutes, secondary antibodies (goat anti-rabbit 
Alexa 680 (or 800), goat anti-rat Alexa 800, or goat anti-mouse Alexa 680 (Invitrogen)) were 
applied for 30 minutes at room temperature. After washing again in PBST, blots were imaged 
using the Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, NE, USA).     
Antibodies 
The following antibodies were used in for immunoblot and immunofluorescence analysis at a 
dilution of 1:2000 or 1:1000, respectively, unless otherwise noted: rabbit anti-PDE6α (Pierce), 
rabbit anti-PDE6β (Pierce), rabbit anti-PDE6γ (Pierce), assembled PDE6 (ROS1) (generously 
provided by Drs. Ted Wensel (Baylor College) and Rick Cote (University of New Hampshire), 
rabbit anti-Transducin-αt1 (Santa Cruz), mouse anti-cytochrome c oxidase subunit I (COX I) 
(MS404 MitoSciences), rabbit anti-Transducin-γt1 (Santa Cruz), mouse anti-GRK1 (Thermo 
Fisher), mouse anti-CNGA1 (UC Davis/NIH NeuroMab Facility), rabbit anti-RDS-c (Peripherin) 
(Gabriel Travis, University of California, Los Angeles, CA), mouse anti-1D4 (rhodopsin) (gift 
from Dr. Ted Wensel, Baylor Collect of Medicine), rat anti-HA antibody (Roche), chicken anti-
RP1 (gift from Dr. Qin Liu Mass. Eye and Ear, Boston, MA), and rabbit anti-ARL2 (1:1000) 
(see above). DAPI (1:1000) (4’,6-diamindino-2-phenylindole, Invitrogen) and  propidium iodide 





Fresh frozen retinal isolates were homogenized in 100 μl per retina of PBS containing protease 
inhibitor (Roche) and 1 mM iodoacetamide. Triton X-100 was added to a final concentration of 
1% and incubated for 1 hour. Debris was removed from the samples by low-speed centrifugation 
(10,000 x g) for 10 minutes and the supernatant was incubated with anti-HA affinity matrix 
(Roche) at 4°C for 2 hours. The HA beads were then washed with PBS + 0.1% TX-100 three 
times for 5 minutes each. Finally, beads were eluted in SDS sample buffer and immunoblot 
analysis was performed as above. 
Immunofluorescence Analysis 
Indirect immunofluorescence was utilized to analyze protein localization in retinal cross-
sections. For general immunofluorescence studies, enucleated eyes were immersed in 4% PFA in 
PBS for 15 minutes, after which the anterior segments were removed and the eyecups were 
placed back in fixative for a total of 3 hours. Fixed eyecups were washed with PBS and kept in 
20% sucrose in PBS overnight at 4°C. After incubation in a 1:1 mixture of 20% sucrose 
solution:OCT (Cryo Optimal Cutting Temperature Compound, Sakura) for 2 hours, eyecups 
were flash frozen in OCT. Alternatively, for staining of ciliary markers anterior segments were 
dissected immediately after enucleation and eyes were placed in 4% PFA for 30 seconds. These 
eyecups were flash frozen in OCT. Serial retinal cross-sections at 16 µm thickness (or 10 μm for 
ciliary markers) were mounted on Superfrost Plus slides (Fisher Scientific). Sections were 
blocked for 1 hour (PBS with 5% goat serum, 0.5% Triton X-100, 0.05% sodium azide) and 
incubated with primary antibody overnight at 4°C then washed with PBS + 0.1% Triton X-100 
three time for 5 minutes. Secondary antibodies (DAPI nuclear stain 405, anti-Rat 568, anti-
Rabbit 488 (or 568), anti-mouse 488 (or 568)) were incubated for 1 hour at room temperature at 
a dilution of 1:1000. Sections were washed again and cover slipped with ProLong Gold (Life 
104 
 
Technologies). Confocal imaging was performed using the Nikon C2 Confocal Microscope 
System. Images were processed using ImageJ image processing software. 
Toluidine Blue Immunohistochemical Analysis 
Eyes were enucleated with the 12 o’clock position marked for reference with a red lipophilic dye 
and immediately fixed in Excalibur Pathology Fixation Buffer at room temperature. Fixed eyes 
were embedded in paraffin, sectioned at 2 μm, and stained with toluidine blue by Excalibur 
Pathology (Norman, OK). Images were captured with a Nikon light microscope. Analysis, 
including measurement of OS, IS, and ONL length was performed using ImageJ.  
Ultrastructural Analysis 
Enucleated eyes fixed in 2% paraformaldehyde, 2.5% glutaraldehyde, 0.1 M cacodylate buffer, 
pH 7.5 for 30 minutes at room temperature were dissected removing the anterior segment and 
lens then fixed further for at least 2 days. Fixed eyecup was dissected into 6-8 wedge-shaped 
pieces. Wedges were dehydrated in a graded ethanol series, and then embedded in Polybed 812 
(PolySciences, Inc., Warrington, PA, USA). Semi-thin (1 μm) sections were collected onto glass 
slides, stained with toluidine blue, and visualized using a Zeiss Axioimager 2 microscope 
equipped with EC Plan-Neofluar 40x (N.A. 0.75) and 100x (1.3 N.A.) objectives. Thin sections 
(ca. 80 nm) from selected wedges were collected onto nickel grids, stained with 2% uranyl 
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FIGURE LEGENDS 
Figure 1. Endogenous Arl2 Expression Profile and Generation of Dominant Active Mutant 
Transgenic Model. This figure illustrates the developmental mRNA expression of Arl2 and 
Arl3 in mouse retina as well as the expression of dominant active ARL2 in our transgenic animal 
model. . A. Arl2 and Arl3 mRNA expression was determined by quantitative PCR of mouse 
retinal tissues from P0 to P16. Expression levels are displayed as fold change relative to the 
expression observed at P0. B. This scheme illustrates the construct used for transgenic mouse 
generation. Human Arl2 Q70L (ARL2 Q70L; glutamine to leucine dominant active mutant) 
expression is driven by a 4.4 Kb rhodopsin promoter (Rhop). The ARL2 Q70L protein is also 
tagged at the C-terminus with hemagglutinin (HA) and FLAG. C. Western blot analysis of 
endogenous versus transgenic ARL2 protein levels in P13 retinal tissue samples by staining with 
ARL2 (red) and HA (green) directed antibodies. Refer to bar graph for quantitation of transgenic 
expression levels relative to endogenous (p <0.01). D. Immunofluorescence analysis of retinal 
cross sections was done at P13 determine the localization of transgenic ARL2 by incubating with 
HA directed antibody (red) and colocalized with the OS marker peripherin (green) (Scale Bar = 
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20 μm). E. Localization of endogenous ARL2 (using ARL2-directed antibody – green) and the 
ciliary marker acetylated tubulin (red) (Bottom Panel). (Scale bar = 10 μm) 
Figure 2. Decreased photoreceptor function in ARL2-Q70L mice. A. Representative scotopic 
(rod) and photopic (cone) electroretinograms (ERGs) comparing Tg(-) and Tg(+) animals at P16 
and P100 across multiple light intensities. B. Graph showing the scotopic a-wave amplitude 
measured at the light intensity of -0.8 log (cd*s/m2) at different ages. * = p < 0.01.  
Figure 3. Rod photoreceptor cells degenerate in animals expressing ARL2-Q70L. A. Retinal 
sections of Tg(-) and Tg(+) littermates stained with propidium iodide to demonstrate the ONL 
integrity at different ages (P13, P60, and P110). B. Quantification of the ONL length (number of 
nuclei) between Tg(-) and Tg(+) littermates at different locations within the retina from the 
inferior (-3) to superior (3) portion at P13 and P110. * = p < 0.01 (Scale Bar = 20 μm). 
Figure 4. Reduction of photoreceptor OS proteins in ARL2-Q70L animals. Representative 
immunoblots showing expression of proteins from retinal lysates of Tg(-) and Tg(+) littermates 
at P13. Quantification of these protein levels is shown in the bar graph on the right. All samples 
were normalized to Gαo, a protein expressed in the bipolar cells. * = p < 0.05. 
Figure 5. Abnormal elaboration of photoreceptor OS in ARL2-Q70L Mice. Representative 
toluidine blue stained retinal cross sections from Tg(-) and Tg(+) littermates at P13 and P16. 
Quantification of the OS, IS and ONL length from these animals at respective ages. * = p < 0.05. 
(scale bar = 20 μm). 
Figure 6. Mislocalization of Rhodopsin in ARL2-Q70L animals. Immunofluorescence 
analysis of OS proteins in Tg(-) and Tg(+) samples at P13. PDE6β (A), Rhodopsin (B), Gαt1 
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(C), and GRK1 (D) with unadjusted image intensity (Top) and enhanced image intensity to 
visualize immunoreactivity in the ONL (Bottom). (Scale Bar = 20 μm). 
Figure 7. ARL2-Q70L expression results in defective ciliogenesis and OS development in 
rod photoreceptor cells. A. Immunofluorescence analysis of retinal cross sections of Tg(-) and 
Tg(+) littermates showing immunoreactivity for DAPI (blue), RPGR (green) and RP1 (magenta) 
(Scale Bar = 10 μm). A frequency distribution illustrating the fraction of total measured cilia 
(length from base of RPGR to tip of RP1 immunoreactivity) ranging between 0-1, 1-2, 2-3, 3-4, 
4-5, and 5+ microns (White arrows indicate mislocalized cilia). B. Electron micrographs of 
retinal cross sections at low magnification of Tg(-) and Tg(+) littermates at P13 illustrating the 
structural abnormalities of the IS, OS, and cilium in Tg(+) (Scale Bar = 2 μm). C. High 
magnification electron micrographs highlighting ultrastructural defects. Black arrows indicate 
misoriented or mislocalized basal bodies and cilia. White arrowheads indicate 
misoriented/dysmorphic OS discs (Scale Bar = 0.5 μm). 
Figure 8. Tubulin binding cofactor D (TBCD) interacts with ARL2 in vivo. 
Immunoprecipitation (IP) of retinal isolates from Tg(-) and Tg(+) ARL2-Q70L using an HA-
directed affinity resin. Immunoblots from IP samples were probed with indicated antibodies. T = 




ARL2 = ADP-Ribosylation Factor-Like 2 
ARL2-Q70L = transgenic dominant active ARL2 
TBCD = tubulin binding cofactor D 
PDE6 = Phosphodiesterase 6 
PDE6α = phosphodiesterase, alpha subunit 
PDE6β = phosphodiesterase, beta subunit 
PDEγ = phosphodiesterase, gamma subunit 
GRK1 = Rhodopsin Kinase (G-protein receptor kinase 1) 
RP = Retinitis pigmentosa 
XLRP = X-linked recessive retinitis pigmentosa 
DAPI = 4’,6-diamidino-2-phenylindole 
ERG = electroretinogram 
OS = outer segment 
ROS = rod outer segment 
COS = cone outer segment 
IS = inner segment 
RIS = rod inner segment 
CIS = cone inner segment 
ONL = outer nuclear layer 
INL = inner nuclear layer 
















































Supplementary Figure 1: Intensity-response relationships for scotopic a-waves recorded at 
P16. The data were fitted with a hyperbolic function to determine a-wave half-saturating light 
intensities of 0.010 ± 0.0019 cd*s/m2 in Tg(+) animals versus 0.014 ± 0.0018 cd*s/m2 in 
littermate controls and calculated maximum a-wave amplitudes of 225.2 ± 6.6 μV (Tg(+)) and 






Supplementary Figure 2. Pan-reduction in photoreceptor OS proteins ARL2-Q70L 
animals. Representative immunoblots showing expression of proteins from retinal lysates of 
Tg(-) and Tg(+) littermates at P16. Quantification of these protein levels is shown in the bar 






Supplementary Figure 3. Mislocalizatoin of Rhodopsin in ARL2-Q70L animals. 
Immunofluorescence analysis of OS proteins in Tg(-) and Tg(+) samples at P16. PDE6β (A.), 
Rhodopsin (B.), Gαt1 (C.), and GRK1 (D.) with unadjusted image intensity (Top) and enhanced 





Chapter 4: Summary and Future Directions 
Photoreceptor cell development and function requires highly complex spatial and temporal 
regulation of protein:protein interactions. There are relatively few insights into how these 
interactions are regulated, however, we do know that they often require the help of small 
GTPases. Although there have been a number of discoveries, research into the role of these 
proteins in photoreceptor cells is in its infancy. Moreover, there are a growing number of 
discoveries linking small GTPases with photoreceptor mediated disease, such as ARL6, ARL2, 
ARL3, and RAB28 (refer to Chapter 1). The purpose of my dissertation was to characterize the 
regulation of photoreceptor cell protein trafficking and OS development by the two small 
GTPases, ARL2 and ARL3. 
 ARL2 and ARL3 are highly homologous proteins sharing 53% identity in primary 
sequence and a high degree of structural similarity in addition to sharing multiple binding 
partners. Using site-directed mutagenesis and transgenesis, we identified the processes that these 
proteins are associated with in vivo. I created multiple animal models including an ARL3-Q71L 
dominant active transgenic model and an ARL3-WT transgenic model (Chapter 2) as well as an 
ARL2-Q70L dominant active transgenic model (Chapter 3). Through these models we 
determined that ARL2 and ARL3 serve different primary functions in photoreceptor cells despite 
having similar binding partners and sequences. Specifically, ARL3 appears to be primarily a 
regulator of trafficking of prenylated proteins to the outer segment, while ARL2 is a crucial 
component of photoreceptor cilia development. 
 The combination of my research (Chapter 2) and the work of Baehr and colleagues, we 
now have a better understanding of the function of ARL3 in vivo. However, these models do 
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have some discrepancies based on the timing of gene disruption or transgenic expression. 
Specifically, embryonic knockout of Arl3 results in improper OS development and early cell 
death while late knockout or expression of a dominant active ARL3 (ARL3-Q71L) (after P4) 
results in defects in prenylated protein trafficking and progressive cell death. My studies have 
implicated sequestration of prenyl binding proteins, like PrBPδ, as the underlying cause of 
prenylated protein trafficking defects, yet we have no clear mechanism underlying the more 
sever defects from early loss of Arl3. Additionally, ARL3-Q71L expression, but no knockout of 
Arl3, results in defective migration of photoreceptor neurons to their proper location, i.e. the 
outer nuclear layer (ONL). The unexplained misdevelopment and early degeneration as well as 
the nuclear migration defect observed in these models provide the primary questions to pursue 
for future research of ARL3. 
 Understanding the discrepancy between early and late degeneration in the knockout 
models will require a better understanding of the role of ARL3 in OS formation or the primary 
underlying process, ciliogenesis. More specifically, the other proteins associated with ARL3 in 
this process must be identified. Although we have performed proteomic analysis from using 
dominant active ARL3 immunoprecipitation from retinal samples, we have yet to identify novel 
binding partners that could explain this phenotype. It is possible that the primary target of ARL3 
the time of OS development is not expressed in adulthood when we performed the 
immunoprecipitation experiments. More extensive proteomic analysis during this timeframe may 
yield novel binding partners that help explain defects in development. In addition, it was recently 
shown that ARL13b can act as a guanine nucleotide exchange factor (GEF) for ARL3, and may 
be responsible for activation of ARL3 in vivo. This would explain the discrepancy in phenotype 
between Arl3 gene disruption and expression of a dominant active protein. Specifically, the 
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interaction of ARL13b and ARL3 may be crucial for OS development. This can be studied by 
genetic models that result in disrupted interaction of these proteins or simply loss of ARL13b.  
The pathway through which ARL3 acts to affect nuclear migration has not been 
identified and the phenotype as not been fully characterized in vivo. Further studies must focus 
on earlier expression of dominant active ARL3 or the combination of endogenous Arl3 knockout 
and expression of ARL3-Q71L. These approaches will produce the most severe phenotype, 
which will provide more insight into the processes involved. It is possible that all cells require 
ARL3 function to have proper nuclear migration. Temporal snapshots can be collected and the 
timing and pattern of migration can be observed. Further proteomic analysis during this 
timeframe may also be required to understand the components involved. Importantly, ARL3 is 
ubiquitously expressed and therefore may play a role in nuclear migration in the cortex. This 
provides an area to expand the research of ARL3 function.   
While the function of ARL3 in vivo has been elucidated in more detail by my own studies 
and previous research from other laboratories, the mechanisms underlying ARL2 regulation of 
photoreceptor development remain very much unclear. Our data suggest that ARL2 may play a 
role in regulation of ciliary growth and localization in photoreceptor cells and subsequently 
affect the morphogenesis of the OS. However, we have yet to determine the details underlying 
these phenotypes. Proteomic analysis of ARL2 binding partners from the dominant active animal 
model may provide insight into the molecular pathway that it is involved in during ciliogenesis. 
Additionally, future experiments must utilize in vitro techniques to determine the function of 
ARL2 on ciliary growth and dynamics. These experiments can be used to explain the potential 
role for ARL2 regulation of TBCD and ARL2BP in the process of ciliogenesis. ARL2 may also 
play a role in energy metabolism by acting at mitochondria in photoreceptor cells. However, it is 
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unclear whether disruption of ATP levels would affect ciliogenesis in photoreceptors. Because 
axonemal growth and microtubule maintenance is an energy dependent process it is certainly 
possible. Further investigation into the function of ARL2 at mitochondria must be completed. 
Finally, as we have seen in the case of ARL3, embryonic knockout may result in a different 
phenotype than a transgenic expression of a dominant mutant, therefore it will be fruitful to 
examine a conditional mouse knockout model of ARL2.  
While this research has established a foundation for the role of ARL2 and ARL3 in 
photoreceptor cells, there are many questions left to be answered. The elucidation of the 
molecular cascades in which these proteins are involved will result in a better understanding of 
ciliogenesis and protein trafficking. This understanding will provide the information necessary 
for the creation of unique therapeutics targeting the underlying mechanisms of photoreceptor 
mediated blinding disease. 
